Abstract
Two-component signaling systems (TCSs) are finely regulated mechanisms by which bacteria adapt to environmental conditions by modifying the expression of target genes. In bacterial pathogenesis, TCSs play important roles in modulating adhesion to mucosal surfaces, resistance to antibiotics, and metabolic adaptation. In the context of urinary tract infections (UTI), one of the most common types infections causing significant health problems worldwide, uropathogens use TCSs for adaptation, survival, and establishment of pathogenicity. For example, uropathogens can exploit TCSs to survive inside bladder epithelial cells, sense osmolar variations in urine, promote their ascension along the urinary tract or even produce lytic enzymes resulting in exfoliation of the urothelium. Despite the usefulness of studying the function of TCSs in in vitro experimental models, it is of primary necessity to study bacterial gene regulation also in the context of host niches, each displaying its own biological, chemical, and physical features. In light of this, the aim of this review is to provide a concise description of several bacterial TCSs, whose activity has been described in mouse models of UTI.
Keywords: UTI, TCSs, mouse models, mutants, virulence genes
1. Introduction
Urinary tract infections (UTI) are one of the most common bacterial infections affecting millions of people in the world each year [1]. UTI are a significant cause of morbidity and is mainly diagnosed in women during their lifetime [2,3]. The higher prevalence of this infection in women is thought to be due to anatomical differences between the male and female genitourinary tracts. Women have a significantly shorter urethra than men and, for this reason, bacteria must travel a shorter distance to reach the bladder from the perianal area, which is the primary colonization site of many uropathogens [4]. The risk for UTI increases with other variables, including age, sexual activity, concomitant pathologies, and previous episodes of UTI [3]. Annually, UTI account for a huge number of visits to physicians and emergency departments as well as hospital admissions and are becoming difficult to treat owing to increased antibiotic resistance [5,6,7,8]. Clinically, UTI can be classified as complicated or uncomplicated. Complicated UTI are associated with predisposing conditions such as urinary tract obstruction, urine retention due to functional abnormalities, and catheterization [9]. These factors may lead to increased bacterial growth and damage of mucosal layers [10]. In this scenario, pathogens may ascend through the ureters into the kidneys, causing renal dysfunction and often leading to pyelonephritis [11]. If patients are not timely treated, bacteremia and septicemia may ensue [12]. On the other hand, uncomplicated UTI affect people without urinary tract abnormalities and tend to involve only the bladder and the lower urinary tract without invasion of the upper urinary tract or systemic infection [13].
The most common agents of complicated and uncomplicated UTI are uropathogenic Escherichia coli (UPEC), Enterococcus faecalis, Klebsiella pneumoniae, Staphylococcus aureus, Proteus mirabilis, group B Streptococcus (GBS), and Pseudomonas aeruginosa [14,15,16,17]. Frequent treatment of patients with antibiotics can result in changes in the normal microbiota of the vagina and the gastrointestinal tract leading to increased risk of urinary tract colonization by multidrug-resistant uropathogens [18,19,20]. For example, among Enterobacteriaceae, E. coli and K. pneumoniae have both acquired resistance to β-lactam antibiotics, while Enterococcus spp. have developed resistance to vancomycin [21].
The initial pathogenetic event in UTI is bacterial adhesion by means of pili and other surface structures and colonization of the urethra [22]. Subsequently, uropathogens must migrate to the bladder and, in this process, they can take advantage of factors that favor their motility, such as increased expression of flagella [23,24,25]. Production of toxins [26,27,28] and proteolytic enzymes [29,30] promotes access of uropathogens to host nutrients. Local replication and avoidance of immune surveillance [31,32,33,34] is also required to allow uropathogens to cause persistent infection, ascend to the kidneys, and access the bloodstream. A common strategy is the pathogen ability to form biofilms either on indwelling devices or directly on the surface of urothelium [35,36]. This mechanism protects uropathogens from the effect of host immunity and antibiotics favoring their persistence in the urinary tract [37,38,39]. Another strategy is the use of various virulence factors to bind to host ligands present in tissues or on the surface of urinary catheters, such as fibrinogen [40], fibronectin [38,41], laminin [42], plasminogen [42,43], and collagen [44]. UPEC and K. pneumoniae, for example, bind to uroplakins which are expressed on the apical membrane of umbrella cells [45]. These data show that urothelial receptors are important players in uropathogen colonization and/or invasion and can be considered as potential targets to reduce recurrent urinary tract infections (rUTI), as defined by three or more UTI in the course of one year [46]. In subverting host defenses, several uropathogens, such as UPEC, invade the urothelial cells and form intracellular bacterial communities (IBCs) by multiplying in the cytoplasm before pouring into the lumen of the bladder [46,47]. In other circumstances, uropathogens may invade deeper layers of the urothelium remaining inside intracellular niches in an inactive metabolic state to be re-activated after exfoliation of the highest layers of urothelium. This response is accelerated by neutrophil recruitment to the urothelium and host secretion of inflammatory cytokines [48,49,50]. Uropathogens may also change their shapes to circumvent the host immune system. Filamentation is a process that blocks septation ring formation and division in UPEC when they emerge from intracellular bacterial communities. In this manner, UPEC resist to neutrophil phagocytosis and can invade other urothelial cells [50]. Alternatively, the interactions between flagella and the host urothelial surface induce morphological changes in the outer membrane of P. mirabilis resulting in the acquisition of a hyper-flagellated phenotype required for increasing bacterial motility and propagation of infection [51,52].
2. Two-component Systems
In bacterial pathogenesis, a central role is played by two-component systems (TCSs). They are involved in sensing various types of stimuli present in the environment such as osmotic pressure, membrane stress, the presence of specific host molecules, pH, antibiotics, and cues associated with intracellular location. TCSs are composed of a sensor histidine kinase (HK) and a response regulator (RR) [53]. The canonical structure of a HK is composed of four main domains: a sensor domain, comprising two transmembrane (TM) helices, an intracellular signal transduction domain (STD) also defined as HAMP (commonly found in Histidine kinase, Adenyl cyclase, Methyl-accepting proteins, and Phosphatase), a cytoplasmic sensor domain, and a conserved intracellular kinase domain that mediates both autophosphorylation and the transfer of a phosphoryl-group to the RR (Figure 1) [54]. The aforementioned kinase domain is composed of the Dimerization and Histidine phosphorylation subdomain, named as DHp, and the Cataytic and ATP-binding (CA) subdomain [54]. The sensor domains of HK are cytosolic or located on the cell surface [54]. The majority of sensor domains can have three types of structural folding: mixed αβ, all-helical or β-sandwich [54]. The response regulators have a simpler structure than HKs. A prototypical RR is made of two domains: a receiver domain and an effector domain. While the first one accepts a phosphoryl group transferred by a cognate HK, the second one triggers the signaling events. Unlike the effector domains, the receiver domains have a sequence where an aspartate residue is well conserved and is phosphorylated by HK. This event results in conformational changes in the receiver domain with the consequent activation of the effector domain. Structurally, the receiver domain has a conserved (βα)5 fold, in which a five-stranded β-sheet is surrounded by α-helices [55]. After the activation of RRs by phosphorylation, several structural changes are induced in some of the α and β elements positioned in the receiver domains, particularly in correspondence of the conserved Thr/Ser and Tyr/Phe key residues [54,56]. Effector domains, also known as output domains, have generally DNA-binding properties and are classified into several subfamilies based on predicted domain structures. The most common effector domains have a winged Helix-Turn-Helix (wHTH) motif or a Helix-Turn-Helix (HTH) motif [57,58,59]. In general, bacteria require numerous TCSs, depending on the specific inputs detected by the various HK. Indeed, metabolic adaptations to the host milieu are dependent on the integration of various TCSs-dependent molecular pathways that need to be investigated in vitro and in vivo.
In addition to information obtained by proteomics and metabolomics analysis, gene expression studies are crucial to understand how TCSs act on the genome. The typical approach is to verify gene expression in mutants deleted either in the RR, HK or both, in comparison with the wild-type (WT) parental strain [60,61]. Furthermore, mutant strains overexpressing the RR may be greatly suitable to examine target gene expression when the activating stimulus is unknown [62]. Various tools are also available to map TCS-targeted sequences and to define signaling networks across different bacterial species or types of infection [63]. In this manner, researchers can understand whether RRs may function as activators, repressors or both. Although biopsies are not frequently performed in patients with UTI, transcriptomic analyses of bacteria present in urine samples from patients provided useful information to analyze in vivo gene expression [64]. Moreover, various mouse models have been developed to study the pathogenesis of UTI [65]. Therefore, identification of TCS-activating stimuli, bacterial signaling mechanisms, and associated transcriptional changes seems relevant to the development of approaches to control infections [66]. In light of this, the aim of this review is to provide a schematic description of the function of some TCSs used by uropathogens focusing on those investigated in mouse models of UTI (Table 1).
Table 1.
TCS | Pathogen |
---|---|
AlgZR | P. aeruginosa |
EnvZ-OmpR | UPEC |
KguSR | UPEC |
CpxRA | UPEC |
BarA-UvrY | UPEC |
GrvRS | E. faecalis |
CovRS | GBS |
2.1. Uropathogenic Escherichia coli
Uropathogenic Escherichia coli (UPEC) is the major cause of UTI in humans with millions of hospitalizations and emergency visits each year [67,68]. UPEC uses several virulence factors to survive in the urinary tract such as pili, hemolysins, and flagella [23,26,69]. The best characterized E. coli virulence factors involved in UTI pathogenesis are surface-exposed or secreted [70] and are schematically listed in Table 2.
Table 2.
Surface Virulence Factors | Main Pathogenic Functions |
---|---|
Type 1 fimbriae | Enhanced bacterial survival; Stimulation of inflammation; Promotion of invasion; Biofilm growth; Binding to uroplakin |
P fimbriae | Binding to kidney glycosphingolipids; |
Bacterial colonization of tubular epithelium | |
S fimbriae | Binding to the lower human urinary tract and kidney; Bacterial dissemination |
Fimbrial Dr | Binding to type IV collagen and to decay-accelerating factor (DAF) |
Adhesin Afa | Establishment of chronic and/or recurrent infection |
Flagella | Bacterial motility; Bacterial ascension from the bladder to kidneys |
Secreted virulence factors | Main pathogenic functions |
α-haemolysin (HlyA) | Lysis of erythrocytes and nucleated cells; Induction of apoptosis of host cells; Exfoliation of bladder epithelial cells |
Cytotoxic necrotizing factor 1 (CNF1) | Kidney invasion; Interference with phagocytosis; Exfoliation of bladder cells |
Secreted autotransporter toxin (SAT) | Damage of bladder or kidney cells |
UPEC belong to the extra-intestinal pathogenic strains (ExPEC) group, which is characterized by a high degree of genetic heterogeneity with an extensive range of different virulence factors. Almost all UPEC strains express type 1 pilus-associated protein FimH that binds to a variety of extracellular matrix components as well as mannose-containing host glycoproteins on umbrella cells [67,71,72]. Moreover, several adhesins, such as F1C pili, S pili, and the autotransporter proteins Upa, mediate the development of biofilms [73,74,75,76]. Biofilm assembly on urinary catheters renders UPEC extremely resistant to antibiotics and host immune responses [76]. Among host receptors implicated in mediating invasion of host cells, integrins [77], the complement regulatory protein CD46 [78], the complement decay-accelerating factor CD55 [79], and the flagellin sensor Toll-like receptor 5 (TLR-5) play major roles [80].
Furthermore, UPEC enter into bladder cells by dysregulating the actin cytoskeleton and promoting a zipper-dependent endocytosis pathway [81]. Once inside bladder cells, UPEC can meet alternative fates, including going back into the extracellular environment [82], replicate intracellularly to create IBCs [83,84] or persist intracellularly without multiplying [85,86]. Intracellular persistence is an effective strategy to avoid the action of antibiotics because of the intrinsic impermeability of the urothelial barrier and the inability of most drugs to cross cell membranes [87]. It is interesting to note that, in order to adapt to host microenvironments, InPEC express virulence factors similar to those expressed by UPEC, including fimbrial adhesins [88,89]. Several of these adhesins are also expressed by other uropathogens, such P. mirabilis and K. pneumoniae, and are considered as suitable targets for anti-adhesive therapeutics [90,91].
While several TCSs have been described in E. coli, relatively few have been analyzed in the context of UTI (Table 3).
Table 3.
TCS | Functional Characterization |
---|---|
EnvZ-OmpR | Sustenance of bacterial growth in urine; Promotion of UPEC ascension along the urinary tract |
KguSR | Colonization of bladder; Regulation of metabolism and cell envelope constituents; Regulation of the c5032-5039 genomic island; |
Sensing of α-ketoglutarate in the urinary tract | |
CpxRA | Resistance to environmental stress; Regulation of HylA expression; Induction of urothelial exfoliation |
BarA-UvrY | Colonization of the bladder and the kidneys; Invasion of urothelial cells; Induction of cellular cytotoxicity |
Since osmolarity can vary considerably in the urinary tract, UPEC has developed strategies to sense external osmolar fluctuations and adapt to these changes [92,93]. One way to accomplish this is the EnvZ-OmpR TCS, which senses osmotic changes, upregulates the expression of the outer membrane porin proteins OmpF or OmpC, and modulates the expression of type 1 pili via activation of the transcriptional regulator OmpR [94,95,96]. The clinical isolate NU149, deleted of the ompR gene (ΔompR), drastically reduced its rate of growth, compared to the WT parental strain, in the presence of increasing NaCl concentrations, whereas complementation with a functional ompR gene restored bacterial growth at WT levels [97]. Furthermore, growth of ΔompR bacteria was further impaired when exposed to high NaCl concentrations in the presence of an acidic pH, thus mimicking the environmental conditions found in human urine. High concentrations of urea and sucrose in the growth medium also led to reduced growth of the ΔompR strain. The phenotype of ΔompR E. coli, was mimicked by strains carrying a single point mutation at position 55, the site of EnvZ-mediated phosphorylation [97].
The mouse urine has a pH ranging from pH 5.5 to 7.0 and osmolarities ranging from 350 to 600 mM [97]. In in vivo studies performed after inoculation of mice with ompR mutants, viable ΔompR bacteria recovered from the bladder were markedly reduced at one-day post-challenge compared with WT bacteria, while there was only a tendency towards lower ΔompR numbers in the kidneys. On the contrary, at the fifth day post-infection, viable ΔompR bacteria were more drastically reduced in the kidneys than in the bladder compared with WT bacteria. Again, complementation of ΔompR bacteria successfully restored the viable counts to WT levels [97]. These studies demonstrate the relevant role played by the response regulator OmpR in promoting UPEC ascension along the urinary tract. Furthermore, these data are in agreement with those of other papers, where mutations in ompR were linked with changes in the E. coli outer-membrane-protein profile and with the notion that OmpR regulates iron acquisition [98] and induces the expression of the IutA protein, both critical for UPEC survival in the urinary tract [99,100].
The TCS KguS/KguR is another signaling pathway that is present in UPEC strains and absent in commensal and diarrheagenic E. coli, suggesting its contribution to UTI [101]. The role of this two-component regulatory system has been first investigated in vivo, by analyzing the ability of ΔkguS/kguR double-deleted strains to colonize the mouse urinary tract. Indeed, the absence of this TCS negatively impacts on colonization of the bladder and kidneys. The analysis of genes targeted by the KguS/KguR system was performed by growing bacteria in human urine to simulate the urinary tract environment. The differentially expressed proteins were grouped into three main categories on the basis of their functions: metabolism, cell envelope constituents, and translational machinery. A xylose isomerase and several outer membrane proteins were found to be overexpressed in a ΔkguR mutant strain, revealing the pleiotropic functions of this TCS. Furthermore, under different growth conditions, constitutive expression of kguR induces the over-expression of the c5035 gene that belongs to a genomic island (c5032-5039) strongly associated with the majority of UPEC strains [101]. Since that UPEC in vivo fitness is impaired when mice are infected with Δc5032-5039 bacteria, researchers have hypothesized that the described TCS may favor UPEC virulence through the regulation of c5032–5039 genes. Indeed, activation of the KguS/KguR regulatory system occurs under anaerobic conditions and is induced by α-ketoglutarate (α-KG) that is converted by a dehydrogenase to succinyl-CoA, which is further transformed to succinate by succinyl-CoA synthetase. In E. coli, α-KG is the only five-carbon (C5) dicarboxylate used as an intermediate in the citric acid/tricarboxylic acid (TCA) cycle, a fundamental process for the supply of metabolic intermediates and energy in catabolic and anabolic reactions [101]. Therefore, sensing external α-KG might represent an outstanding and unique strategy for UPEC to activate pathogenic mechanisms in anaerobic niches, given the absence of a functional α-KG dehydrogenase in all E. coli. Indeed, in the kidney, proximal tubule cells produce greater quantities of α-KG compared to any other cell type [102], suggesting a role of the KguS/KguR TCS in increasing UPEC fitness during in vivo infection. Moreover, deletion of the histidine kinase determines the downregulation of several genes belonging to the c5032-5039 genomic island in the presence of α-KG, underlying the importance of phosphorylation of the response regulator KguR.
As mentioned above, a major property of UPEC is to adhere to and invade urothelial cells where it can replicate inside the cytoplasm, forming highly proliferative intracellular communities that rapidly detach and infect neighboring epithelial cells [46,103]. In order to reduce bacterial colonization, the host accelerates exfoliation of the superficial layer of the urothelium, which however carries a risk of promoting bacterial dissemination. This may lead to the onset of chronic cystitis or the establishment of intracellular bacterial reservoirs [83,86,104].
Almost half of pathogenic E. coli strains isolated by patients with UTI expresses an α-hemolysin (HlyA), mainly involved in in vivo urothelial damage [105,106]. Moreover, HlyA lyses several mammalian cells after its assembly into a water-filled channel that perforates the cell membrane [26,107,108]. It also negatively modifies the cell–cell and cell–matrix interactions promoting exfoliation [109]. Notably, HlyA expression is directly down-regulated by a TCS named CpxRA [110,111,112], that is critical for enhancing UPEC infection in the urinary tract. The CpxRA TCS is composed of an inner membrane sensor with a histidine kinase activity, named CpxA, and of CpxR, the cytoplasmic response regulator. When the bacterial envelope is subjected to stress, CpxA autophosphorylates and, in turn, phosphorylates CpxR which can regulate gene expression. In addition to HlyA downregulation, CpxR is involved in the control protein folding, reduction of envelope stress [113,114], regulation of biofilm assembly [115,116] promotion of bacterial adherence [76] and motility [110,117], and activation of secretion systems [118]. The CpxRA TCS is known to induce the expression of CpxP, a small periplasmic protein that can inactivate the sensor kinase CpxA [119,120]. In addition, CpxP also interacts with unfolded proteins that are subsequently degraded by the protease DegP in order to control incorrect activation of CpxA in the absence of envelope stress [121].
In a mouse model of transurethral infection, viable ΔcpxRA bacteria were reduced in number compared with the WT UTI189 strain [122]. In contrast, absence of CpxP had no effect on in vivo infection. Furthermore, in vitro exposure to molecules inducing generalized stress, such as reactive nitrogen and oxygen radicals or factors damaging the bacterial membrane, did not affect the growth of ΔcpxRA and ΔcpxP bacteria, underlying how the environmental stress sensed by CpxA is specifically associated with in vivo infection. Nagamatsu K. et al. [123] have found that the human cystitis isolate UTI189 deleted for the response regulator CpxR (ΔcpxR) is more hemolytic than its wild-type parental strain due to increased HlyA expression and that the recombinant CpxR protein interacts with the hlyA promoter in an electrophoretic mobility shift assay (EMSA). By investigating in vivo bladder colonization by UPEC, it was possible to evidence a direct correlation between the CpxRA function, HlyA production, and exfoliation of the urothelium. The bladder colonization rate at 16 h post infection was significantly reduced using the ΔcpxR strain or a strain overexpressing hylA (WT/phlyCABD), compared to WT, ΔhlyA, ΔcpxRΔhlyA, and complemented ΔcpxR strains [123]. This indicated that excessive production of the HlyA cytotoxin in the absence of a functional CpxRA TCS negatively impacts the ability of UPEC to colonize the bladder. To measure exfoliation in infected mouse bladders, an elegant approach is to observe the distribution and abundance of binucleated superficial facet cells by DAPI-staining of bladder preparations. Since superficial cells also express high amounts expression of uroplakin III, a marker of terminal differentiation, facet cell abundance can be estimated by uroplakin III quantification in homogenized mouse bladders [123]. By either method, marked reductions in facet urothelial cells were observed in bladders infected with ΔcpxR and WT/phlyCABD bacteria. Cellular exfoliation is a mechanism that, on the one hand, eliminates superficial infected urothelial cells and, on the other hand, exposes underlying layers of the urothelium to UPEC with a potentially increased risk of deeper bacterial invasion. For these reasons, it is important to understand the mechanism leading to death and exfoliation of urothelial cells and their significance in terms of host defenses. Exfoliation is governed by different pathways that often involves activation of the caspase family of cysteine proteases, as evidenced in models using Staphylococcus aureus infection [124]. In the paper by Nagamatsu et al. [123], it was found that HylA over-expression in ΔcpxR bacteria triggers, in human cultured urothelial cells, a proinflammatory form of cell death called pyroptosis, through activation of Caspase-1/Caspase-4 and release of IL-1α and IL-1β, as evidenced using chemical inhibitors or siRNA-mediated knockdown of Caspase-1, Caspase-4, and NLRP3. Indeed, these treatments determined a significant reduction in the release of cytoplasmatic lactate dehydrogenase (LDH), IL-1α, and IL-1β from urothelial cells infected with UPEC ΔcpxR and WT/phlyCABD strains [123]. Furthermore, fluorescence microscopy revealed the activation of Caspase-1/Caspase-4 as HylA-overexpressing bacteria were surrounded by visible speckles which, conversely, were not visible in ΔhlyA or ΔcpxRΔhlyA-infected cells. These results were also confirmed in the in vivo UTI model by increased expression of mCasp11, Nlrp3, Il1α, and Il1β genes and cleaved Caspase-1 in bladders of mice infected with ΔcpxR bacteria [123]. Administration of a Caspase-1/mCaspase-11 inhibitor to mice infected with the ΔcpxR strain restored acute virulence of this mutant to WT levels, concomitantly with a reduction of epithelial exfoliation and inflammatory infiltrates [123]. Collectively, these data show that downregulation of hylA expression by the CpxRA TCS is fundamental for UPEC to evade host defenses associated with pyroptotic cell death, increased exfoliation, and induction of inflammatory responses.
The E. coli BarA-UvrY TCS has been previously described as a signaling mechanism used to withstand osmotic stress, as shown using barA mutants [125,126]. In addition, the BarA-UvrY system regulates expression of the csrA gene, whose product controls flagellar assembly, carbon metabolism, and biofilm formation [125,126,127,128,129]. In mouse models of ascending UTI, it has been shown that bacteria devoid of barA are impaired in their ability to colonize the bladder and the kidneys [130]. Similarly, uvrY-deleted UPEC were impaired in their ability to colonize the mouse bladder and invade urothelial cells in vitro [130]. Furthermore, when this TCS is active, cytotoxicity for human kidney cells is augmented, as exemplified by observations that supernatants from the uvrY-deleted strain are unable to affect cell viability. Conversely, the effects of barA mutation are not as evident as those described for uvrY in this system [130].
2.2. Pseudomonas aeruginosa
Pseudomonas aeruginosa is an opportunistic pathogen that is the third most common cause of UTI. These infections can be acute or chronic and is often difficult to eradicate because of antibiotic resistance. Acute infections are often characterized by a rapid progression [131], while chronic infections appear to be associated with slower bacterial growth, biofilm formation, and antibiotic resistance [132]. Furthermore, this microorganism is linked to infections in immunocompromised patients [133,134]. A multitude of virulence factors, particularly those associated with bacterial colonization and tissue invasion, play important roles in the pathogenesis of P. aeruginosa UTI. The main P. aeruginosa extracellular appendages are fimbriae and pili that are required for the initial adhesion to host surfaces [135,136], while polysaccharides are involved in maintenance of bacterial communities, including biofilm formation [136,137]. The genome of P. aeruginosa contains numerous TCSs which allow bacteria to recognize and respond to environmental signals in a highly complex manner. The best studied TCSs in the context of P. aeruginosa pathogenesis are associated with biofilm formation, motility, and production of cytotoxins such as pyocyanin [138].
Biofilms are complex communities of bacterial cells enclosed in an extracellular matrix composed of lipids, polysaccharides, and extracellular DNA (eDNA) [139]. Biofilm assembly is the result of important stages involving reversible attachment, irreversible adherence to surfaces, microcolony formation, maturation, and dispersion. P. aeruginosa produces robust biofilms on the surface of human tissues and implanted devices and extracellular polysaccharides, such as Pel, Psl, and alginate, are of major importance in the formation and stability of a microbial biofilm community. Biofilm formation enables the pathogen to become tightly associated with a favorable habitat and to further evade the host immune attack [140]. In UTI, such as CAUTI, biofilms formed by P. aeruginosa seem not to require alginate. A model has been proposed whereby pyocyanin, a secreted virulence factor, may promote biofilm formation by increasing the viscosity of eDNA [141].
In this context, TCSs control the change from a planktonic to a sessile lifestyle and vice versa in response to external stimuli by differently regulating the expression of several virulence genes. The initial attachment of bacteria to biotic or abiotic surfaces is an important step in biofilm assembly, in which several surface-exposed components, such as flagella, type IV pili and fimbriae, are involved (Table 4). The TCS PilSR regulates, for example, type IV pilus expression [142], while the FleSR TCS controls the formation of flagella, which increase the hydrophobicity of the bacterial surface and facilitate reversible binding to abiotic surfaces [143]. An additional TCS involved in the initial phases of P. aeruginosa biofilm formation is the Roc system, where RocS1 and RocA1 are sensor HK and RR, respectively. The Roc system favors the expression of cupB and cupC gene clusters, each containing a minimal set of genes required for the expression of adhesive fimbrial organelles belonging to the chaperone/usher family [144]. The BfiSR TCS is, instead, involved in the bacterial irreversible attachment through transcriptional regulation of the RNase G, which modulates the levels of a small RNA (rsmZ), belonging to a well-characterized small RNA-based regulatory system [145]. The KinB-AlgB TCS (in which KinB is the HK and AlgB the transcriptional activator) is involved in the direct regulation of algD [146], a gene required for alginate biosynthesis and in the onset of mucoid phenotypes as suggested by acute pneumonia murine models [147]. Moreover, an AlgB-independent role of KinB has been demonstrated in models of acute infections in zebrafish embryos [148]. BfmR is a response regulator that modulates the release of eDNA, which is required for biofilm maturation and integrity [149] and the deletion of its cognate sensor regulator BfmS causes a significant reduction of the recovered bacteria from infected murine lungs [150]. The high rate of BfmR phosphorylation and enhanced chronic infection state has been further linked to single point mutations found in the sensor BfmS of clinical isolates [151]. PprAB, another important TCS, controls the expression of the cupE gene cluster responsible for the regulation of cell-to-cell connections not only during microcolony formation but also in the final maturation of biofilms [152]. Finally, modulation of rhamnolipids and other signaling molecules is associated with the ability of the TCS BqsSR to promote biofilm dispersal, as assessed by experimental approaches performed with ΔbqsS and ΔbqsR bacteria [153]. In the context of UTI, rhamnolipid expression is upregulated under the iron-limiting conditions of the urinary tract, enabling P. aeruginosa ascension and persistence [154].
Table 4.
TCS | Step in Pathogenesis | Virulence Factor |
---|---|---|
PilSR FleSR Roc system BfiSR KinB-AlgB BfmSR PprAB BqsSR |
Biofilm formation | Type IV pili Flagella Fimbriae RnaseG Alginate eDNA Fimbriae Rhamnolipids |
FleSR GacSA CarsR PilSR FimS-AlgR |
Motility | Flagella sRNAs CarP Pili Pili |
GacSA-LadS-RetS BqsSR AlgZR |
Pigment formation | Pyocyanin |
Pyocyanin | ||
Pyocyanin | ||
GtrS-GltR Roc system CbrAB GacSA |
Release of extracellular virulence factors | ToxA ExoY and Exo T ExoS |
Elastase |
P. aeruginosa uses three different types of motility to colonize the host: swimming, swarming, and twitching. The role of P. aeruginosa motility in UTI is not clear. A report dealing with a limited number of isolates showed an increased bacterial ability to swarm in UTI compared to CAUTI, whereas in the context of CAUTI, swarming was lower in chronic conditions compared to acute ones [155]. The swimming process involves the rotation of a single flagellum, while swarming requires intercellular coordination among bacteria to progress on surfaces, and twitching involves continuous length changes of type IV pili. Several TCSs have been also described referring to motility (Table 4). The FleSR TCS governs flagellar biosynthesis while the GacSA system works together with other membrane sensors to finely regulate sRNAs associated with intracellular signals triggering in acute infection [143,156]. Other studies demonstrated how the CarSR regulatory system regulates swarming motility by sensing external Ca2+ concentrations [157] and how PilSR is responsible of pilus- and flagellum-dependent swimming motility [142]. In contrast to flagella, type IV pili are used by P. aeruginosa to move by alternating ATP-dependent elongation and retraction phases [158]. The FimS-AlgR, for example, controls the twitching motility by enhancing the expression of genes involved in pili assembly [159], whereas phosphorylation of the response regulator PilG is useful to facilitate pilus extension [160].
P. aeruginosa produces pyocyanin whose cytotoxic effects have been well characterized [161]. Pyocyanin production is regulated by several Quorum Sensing (QS) systems, but the role played by TCSs is also crucial (Table 4). The association of GacSA with the sensors LadS and RetS is important in the expression of phz operons encoding for the pyocyanin precursors such as chorismic acid [162]. The BqsSR system positively regulates the 2-heptyl-3-hydroxy-4-quinolone (PQS) that is essential for pyocyanin production [153], whereas a non-functional BqsSR system decreases pyocyanin synthesis [153]. The AlgZR TCS regulates indirectly pyocyanin production through the repressor CzcR and an interesting role has been ascribed to phosphorylation of the regulator AlgZR in acute murine wound and pneumonia models of infections [163].
In the course of pathogenesis, P. aeruginosa secretes numerous toxins and hydrolytic enzymes through different types of secretion systems. Secretion system type II and III are the most important. The type II system favors the secretion of the chitin-binding protein E and D (CbpE and CbpD, respectively), elastase or exotoxin A (also named as ToxA) [164,165]. Conversely, the type III system promotes the secretion of ExoS, ExoT, ExoU, and ExoU by playing, in this manner, a relevant role in host damage and immune response dysfunction. Clinical P. aeruginosa isolates from UTI have revealed higher levels of ExoS compared to tracheal isolates [166]. The GtrS-GltR TCS is engaged in ToxA production [167] and gtrS mutant bacteria are unable to greatly infect murine lungs [168], while the GacSA system controls elastase and type III secretion systems [169]. Moreover, the Roc system is involved in the production of ExoY and ExoT toxins [169], compared to CbrAB that determines the synthesis also of ExoS toxin [170]. Furthermore, the role of the sensor kinase CbrA has been investigated in murine peritoneal and lung infection models by showing a loss of virulence for cbrA mutant and ruling out the involvement of alterations in bacterial motility, biofilm formation, and cytotoxicity [171]. Contrarily, the FimS-AlgR system negatively regulates type III secretion [172] (Table 4).
Antimicrobial resistance is not only associated with both biofilm formation, but also intracellular persistence [173]. It has been demonstrated that P. aeruginosa can survive inside human bladder epithelial cells and stably reside in intracellular reservoirs by means of the two-component regulator AlgZR [174]. As mentioned above, AlgR is an important virulence factor regulator, controlling type IV pilus-dependent twitching motility and alginate production (via regulation of algC and algD promoters). It also negatively regulates biofilm formation, quorum sensing, and anaerobic metabolism [175]. Both laboratory and clinical strains were found to remain alive intracellularly for up to 48 h, as shown by gentamicin protection assays and by confocal imaging revealing Pseudomonas aeruginosa co-localization with the intracellular marker of endocytosis LAMP-1 [174]. Deletion of the algR gene is associated with decreased intracellular survival, compared to WT bacteria. Like other two-component response regulators [53], AlgR is activated after being phosphorylated by the histidine kinase AlgZ (or FimS) [175]. Deletion of algZ results in reduced invasion and intracellular survival, suggesting that phosphorylation of AlgR might be involved in these phenomena. An interesting mutational approach to investigate the activation of a response regulator by its cognate histidine kinase is to create a single point mutation in the predicted RR phosphorylation site. Mutants with a non-phosphorylated (D54N) form of AlgR (AlgR phosphoablative, locked into the constitutive, non-activated state) were defective in bladder cell invasion, while a phosphomimetic (D54E) mutant locked into the activated state invaded cells similarly as WT bacteria [174].
Bacterial adaptation to the intracellular host environment is associated with transcriptional changes that can be studied in depth by using transcriptomic, or RNA-seq, analysis [176], although it is not always technically easy to recover sufficient amounts of bacterial RNA for this kind of studies. After invasion of bladder epithelial cells, wild-type bacteria upregulate genes encoding virulence factors, such as the type III secretion system and iron acquisition proteins such as pyocyanin and pyoverdin [177,178], while downregulate genes related to arginine catabolism and lipopolysaccharide synthesis, which were previously found to be overexpressed by extracellular bacteria in a murine pneumonia model [178]. Conversely, by comparing transcriptional profiles of WT and ΔalgR bacteria, seven genes involved in protein translation and in transmembrane protein synthesis were shown to be downregulated in the ΔalgR strain. Moreover, low amounts of ribosomal RNA (rRNA) were detected in the ΔalgR strain, suggesting that even in the first stages of P. aeruginosa internalization into bladder cells, bacteria without the response regulator AlgR may be incapable of surviving in the intracellular compartments because of deficiencies in their translational machinery [174].
On the other hand, in the course of bacterial infection, the host changes its transcriptional activity to counteract the invading pathogen. In light of this, information on the host, in addition to the pathogen, transcriptional responses may be useful to understand the mechanisms of intracellular infection by P. aeruginosa. Dual RNA-seq studies indicated that activation of NF-κB-dependent genes in bladder epithelial cells is exploited by P. aeruginosa to survive intracellularly [174]. For example, blockade of NF-κB signaling with chemical inhibitors reduced intracellular survival of wild-type P. aeruginosa. NF-κB-dependent bacterial survival in bladder cells is paradoxical, since the same NF-κB pathway was previously found to be required for inflammatory responses and clearance of extracellular P. aeruginosa in a pneumonia model [178].
To study the role of the AlgZR TCS in vivo, mice were transurethrally infected with P. aeruginosa and bladders were harvested to measure colony forming units (CFU). After 2 h of infection, a high number of WT bacteria was recovered intracellularly and was found to persist for up to 7 days in almost all infected mice. On the contrary, deletion of algR resulted in low and transient intracellular bacterial burden in the bladder [174].
In light of these data, the authors went on to demonstrate that P. aeruginosa survival inside epithelial cells contributes to the onset and recurrence of chronic infection. Furthermore, persistent infections by uropathogens are strictly related to antibiotic resistance [179] and, in the case of P. aeruginosa, the discovery of therapies targeting the host inflammatory pathways such as NF-κB signaling could be an intriguing approach to control infections of the urinary tract.
2.3. Enterococcus faecalis
Enterococcus faecalis is a Gram-positive bacterium responsible for CAUTI. Implantation of a urinary catheter in the bladder evokes histological changes [180], inflammation [181], and the release of fibrinogen which coats the catheter [182]. Binding to the extracellular matrix has been described for different enterococcal proteins, such as Ace (adhesin of collagen from enterococci) and E. faecalis surface proteins (Fss). While Ace binds to collagen types I and IV, laminin, and dentin [183,184], Fss proteins bind to fibrinogen [185]. Recent studies demonstrated that enterococcal membrane glycolipids recognize the glycosaminoglycans heparin and heparan sulfate present on human colonic cells to mediate bacterial adhesion to host tissues [186]. E. faecalis harbors two pilin gene clusters (PGCs), named ebp locus (standing for endocarditis and biofilm-associated pili) [187] and the bee locus (biofilm enhancer in enterococci) [188], both contributing to the pathogenesis of endocarditis and urinary tract infection. Esp proteins facilitate the E. faecalis adherence to fibrinogen and collagen receptors present in bladder cells in the mouse model. In addition, in vivo studies show that Ebp regulate the biofilm formation during CAUTI [37]. Gelatinase is, instead, a protease used by E. faecalis to control biofilm formation and its expression is increased by the fsr TCS which is composed of four genes (fsrA, fsrB, fsrD, and fsrC) [189]. This system is activated in response to a peptide lactone, which is encoded by fsrD [189]. As far as we know, the two-component regulatory system GrvRS, which directly controls ace transcription [190], is the only one to have been investigated in UTI. Bacteria deleted for grvR (ΔgrvR) are impaired in their ability to colonize the urinary tract and, conversely, complementation of ΔgrvR restores in vivo virulence. Moreover, the absence of GrvR determines a reduction in binding to Ace extracellular matrix targets and biofilm formation.
2.4. Streptococcus agalactiae
Group B streptococcus (or GBS) is a Gram-positive commensal of the human gastrointestinal and genital tract flora in almost 30% of healthy women [191,192]. This bacterium is one of the leading causes of infection in newborns [193] and adults with chronic pathologies [194]. It can cause sepsis and meningitis in neonates after infection in utero or during passage through the birth canal in the first week of life (early onset disease). Neonates can also acquire infection at later times and develop late-onset disease, predominantly associated with meningitis. In addition to neonatal infection and sepsis in adults, this pathogen can be also responsible for UTI, accounting for approximately 2–3% of all UTI [5,195]. GBS UTI includes asymptomatic bacteriuria (ABU), cystitis, pyelonephritis, and urosepsis [196,197]. Furthermore, GBS UTI during pregnancy carries a high risk of chorioamnionitis and premature labor [198,199]. While the actual prevalence of GBS UTI is uncertain, GBS ABU detected during pregnancy is a clear indication of maternal genital tract colonization [199,200]. Indeed, GBS ABU has been associated with a high risk for early-onset disease (EOD) in newborns [199,201] and, for this reason, must be taken into consideration for intrapartum antibiotic chemoprophylaxis in conjunction with other factors [202]. In contrast to other pathological conditions caused by GBS, the clinical and molecular mechanisms of GBS UTI are not well understood. Some studies have shown that the secretion of inflammatory mediators, in mouse models of transurethral infection is induced during serotype III GBS strains infection [195,203,204], but only few studies have described the role played by known GBS-virulence factors in this context. For example, sialic-acid residues of the capsular polysaccharide are likely to play a role for infection of the urinary tract [202,205], whereas β-hemolysin/cytolysin (β-h/c) can elicit a strong neutrophil response in the murine bladder because of its cytotoxic effect on uroepithelial cells [16].
As other organisms, GBS encounters different environmental niches and uses several systems to sense external signals in order to ensure its survival and efficiently colonize the host [206,207]. GBS has more than 20 different two-component systems that have been classified in different categories on the basis of their functions, such as resistance to antibiotics, adhesion to the mucosal surfaces, metabolic regulation, and pathogenesis [208]. The majority of widely adopted TCS by GBS has been investigated in mouse infection models (Table 5).
Table 5.
TCS | In Vivo Mouse Model | References |
---|---|---|
CovRS | Meningitis | [209] |
CovRS | Meningitis | [210] |
CovRS | Vaginal | [211] |
HssRS | Systemic infection | [212] |
LtdRS | Vaginal | [213] |
RgfAC | Meningitis | [214,215] |
SaeRS | Vaginal | [216] |
FspSR | Vaginal | [214] |
LiaSR | Sepsis/pneumonia | [217] |
NsrRK/BceRS | Intraperitoneal | [218] |
CiaRH | Meningitis | [219] |
One of the most studied TCS in GBS is the CovRS regulatory system where the sensor histidine kinase CovS senses external signals and activates the response regulator CovR [220]. This system directly or indirectly regulates the expression of different genes [221], including those encoding virulence factors, such as β-hemolysin/cytolysin (β-h/c) [222], HvgA [223], PbsP [209,224,225,226], and other ones. Furthermore, pbsP is subjected to the transcriptional regulation mediated by the recently discovered SaeRS TCS that greatly enhances its expression by rendering GBS more virulent in vivo [216]. Studies on SaeRS correlation with pbsP are currently underway among different clonotypes and in other in vivo infection models, given the importance of this adhesin in GBS pathogenesis [209,224,225,226].
CovR is particularly involved in favoring the transition from commensalism to virulence by controlling the expression of more than 150 genes. Until now, only a paper briefly describes the in vivo contribution of this TCS to the onset of UTI [227]. Infection assays using a covR-deficient mutant demonstrate significant attenuation in the ability of GBS to colonize the bladder and urine in a mouse model. Furthermore, the levels of pro-inflammatory cytokines, such as interleukin 6, 17A, 12, and chemokines, are lower in response to bacteria lacking CovR compared with the WT strain upon bladder infection. In contrast, other innate immune mediators are equally overexpressed by both WT and covR-deficient strains. In vitro experiments on bladder cells corroborate the idea that CovR is involved in cellular adhesion and invasion and in acute GBS-induced cytotoxicity. Indeed, fluorescence images revealed co-localization of ΔcovR bacteria and Caspase 3 (an executioner of apoptosis), a feature that correlates with the hyper-hemolytic phenotype of the mutant strain. This observation is in line with the described role of β-h/c in S. agalactiae UTI [16]. As a pathogenic strategy, GBS is able to alter the expression of CovR in vivo to finely modulate virulence genes expression on the basis of the host niches encountered [228]. This CovR properties are in line with other in vivo models of GBS infection. For instance, in murine sepsis models, the absence of CovR results in the recovery of increased numbers of bacteria in infected brains [210]. Moreover, covR-deficient bacteria are less invasive in human vaginal epithelial cells [211].
2.5. Proteus Mirabilis
Proteus mirabilis is a leading cause of pyelonephritis, urolithiasis and is, particularly, associated with long-term catheterization [229,230]. Proteus has several virulence factors such as fimbriae or appendages mediating adherence to cells of the urinary tract and also to catheters [231,232,233]. Furthermore, this pathogen produces urease that uses ammonia as substrate by increasing pH with the subsequent precipitation of calcium and magnesium ions and the formation of urinary stones that can reduce urinary flow with consequent tissue damage [234,235]. The precipitation of minerals may further promote bacterial adherence to the catheter, laying the foundations for biofilm formation [36,236]. Subsequently, bacteria embedded in urinary stones may evade the host immune response and/or the efficacy of antibiotics [237]. These conclusions were reached using a mouse model of UTI where the absence of the gene encoding for urease significantly decreased the number of recovered bacteria from kidney and bladder [238]. P. mirabilis migrates along catheters by means of a swarming process to migrate along the urinary tract [239,240], even though non-swarming mutants progress only on latex catheters coated with hydrogels [241]. Moreover, in P. mirabilis biofilms, swarm cells have been observed and proposed as mediators of bacterial dispersal from catheter to the urinary tract [242]. As far as we know, few TCSs have been characterized in P. mirabilis, but not in the context of murine urinary tract models of infection. The RppAB TCS regulates the synthesis of LPS and flagella. RppA is, indeed, a regulator of arnA gene that encodes for a bacterial decarboxylase useful for LPS modification [243]. A mutated rppA gene is also linked to a more evident swarming phenotype [244]. Another recent paper has also highlighted the role played by the QseEF TCS in modulating swarming motility. In general, the activated sensor kinase QseE determines the phosphorylation of the regulator QseF that, in turn, activates the expression of GlmY together with CheA and RcsB, two antagonist regulators of flagellum production [245]. A recent case report has described evidence of acquisition of resistance to imipenem and amikacin in a Proteus mirabilis clinical isolate, not previously showing this feature. Sequencing revealed the appearance of a point mutation (His-208-Pro) in the HAMP domain of the CpxA sensor [246]. This observation is in line with that seen in the CpxA of other microorganisms revealing resistance to β-lactams and major expression of efflux pump [247] by indicating how relevant is the role played by TCS in antibiotic resistance [248].
3. Conclusions
UTI represents a widespread health emergency [1,8]. Uropathogens produce a wide range of virulence factors that are essential for early attachment to host tissues and for the establishment of infection [17]. Furthermore, the majority of UTI is largely associated with antibiotic resistance [19]. Treatment of patients with antimicrobial drugs is progressively leading to the alteration of the normal microbiota leaving open field to recurrent UTI [19,20]. Intense efforts are, therefore, needed to identify selective targets that may be blocked in order to dysregulate bacterial pathogenetic mechanisms. A special feature of bacterial pathogenesis is the continuous change of transcriptomic profiles by means of TCS to enhance survival, proliferation, and spreading in the host. These systems combine signal recognition, signal transduction, and gene activation by using a sensor and a response regulator [53,249]. More than one TCS is likely involved in the onset of infection and extensive networking among them is required to produce complex responses that allow bacteria to endure in hostile niches. Notably, two-component proteins from different bacterial species share similar amino acid motifs located near the activation site [249] and a high degree of structural homology [250], leading us to hypothesize that deeper knowledge of these general features may be extremely relevant for the development of new therapeutic strategies [251]. Main molecular targets may include auto-phosphorylation sites in the sensor, phosphoryl transfer to the response regulator, and binding of RR to the gene promoter [251]. For this reason, it is of considerable importance to obtain a more detailed characterization of TCS signaling pathways under both in vitro and in vivo conditions with the final goal of controlling UTI.
Author Contributions
G.V.D.G. conceptualized and wrote the manuscript; G.L., A.F. and F.C. provided critical feedback and helped shape the manuscript; C.B. contributed to the final revision of the manuscript. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
Funding Statement
This research received no external funding.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Dis. Mon. 2003;49:53–70. doi: 10.1067/mda.2003.7. [DOI] [PubMed] [Google Scholar]
- 2.Foxman B., Barlow R., D’Arcy H., Gillespie B., Sobel J.D. Urinary tract infection: Self-reported incidence and associated costs. Ann. Epidemiol. 2000;10:509–515. doi: 10.1016/S1047-2797(00)00072-7. [DOI] [PubMed] [Google Scholar]
- 3.Scholes D., Hooton T.M., Roberts P.L., Stapleton A.E., Gupta K., Stamm W.E. Risk factors for recurrent urinary tract infection in young women. J. Infect. Dis. 2000;182:1177–1182. doi: 10.1086/315827. [DOI] [PubMed] [Google Scholar]
- 4.Dielubanza E.J., Schaeffer A.J. Urinary tract infections in women. Med. Clin. N. Am. 2011;95:27–41. doi: 10.1016/j.mcna.2010.08.023. [DOI] [PubMed] [Google Scholar]
- 5.Foxman B. The epidemiology of urinary tract infection. Nat. Rev. Urol. 2010;7:653–660. doi: 10.1038/nrurol.2010.190. [DOI] [PubMed] [Google Scholar]
- 6.Echols R.M., Tosiello R.L., Haverstock D.C., Tice A.D. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis. Clin. Infect. Dis. 1999;29:113–119. doi: 10.1086/520138. [DOI] [PubMed] [Google Scholar]
- 7.Hatfield K.M., Dantes R.B., Baggs J., Sapiano M.R.P., Fiore A.E., Jernigan J.A., Epstein L. Assessing Variability in Hospital-Level Mortality Among U.S. Medicare Beneficiaries with Hospitalizations for Severe Sepsis and Septic Shock. Crit. Care Med. 2018;46:1753–1760. doi: 10.1097/CCM.0000000000003324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Foxman B. Urinary tract infection syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. N. Am. 2014;28:1–13. doi: 10.1016/j.idc.2013.09.003. [DOI] [PubMed] [Google Scholar]
- 9.Lichtenberger P., Hooton T.M. Complicated urinary tract infections. Curr. Infect. Dis. Rep. 2008;10:499–504. doi: 10.1007/s11908-008-0081-0. [DOI] [PubMed] [Google Scholar]
- 10.Nielubowicz G.R., Mobley H.L. Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 2010;7:430–441. doi: 10.1038/nrurol.2010.101. [DOI] [PubMed] [Google Scholar]
- 11.Katchman E.A., Milo G., Paul M., Christiaens T., Baerheim A., Leibovici L. Three-day vs longer duration of antibiotic treatment for cystitis in women: Systematic review and meta-analysis. Am. J. Med. 2005;118:1196–1207. doi: 10.1016/j.amjmed.2005.02.005. [DOI] [PubMed] [Google Scholar]
- 12.Hsu D., Melzer M. Strategy to reduce E. coli bacteraemia based on cohort data from a London teaching hospital. Postgrad. Med. J. 2018;94:212–215. doi: 10.1136/postgradmedj-2017-135454. [DOI] [PubMed] [Google Scholar]
- 13.Hooton T.M. Clinical practice. Uncomplicated urinary tract infection. N. Engl. J. Med. 2012;366:1028–1037. doi: 10.1056/NEJMcp1104429. [DOI] [PubMed] [Google Scholar]
- 14.Mittal R., Aggarwal S., Sharma S., Chhibber S., Harjai K. Urinary tract infections caused by Pseudomonas aeruginosa: A minireview. J. Infect. Public Health. 2009;2:101–111. doi: 10.1016/j.jiph.2009.08.003. [DOI] [PubMed] [Google Scholar]
- 15.Kitano H., Shigemoto N., Koba Y., Hara T., Seiya K., Omori K., Shigemura K., Teishima J., Fujisawa M., Matsubara A., et al. Indwelling catheterization, renal stones, and hydronephrosis are risk factors for symptomatic Staphylococcus aureus-related urinary tract infection. World J. Urol. 2021;39:511–516. doi: 10.1007/s00345-020-03223-x. [DOI] [PubMed] [Google Scholar]
- 16.Leclercq S.Y., Sullivan M.J., Ipe D.S., Smith J.P., Cripps A.W., Ulett G.C. Pathogenesis of Streptococcus urinary tract infection depends on bacterial strain and β-hemolysin/cytolysin that mediates cytotoxicity, cytokine synthesis, inflammation and virulence. Sci. Rep. 2016;6:29000. doi: 10.1038/srep29000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Govindarajan D.K., Kandaswamy K. Virulence factors of uropathogens and their role in host pathogen interactions. Cell Surf. 2022;8:100075. doi: 10.1016/j.tcsw.2022.100075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Spees A.M., Wangdi T., Lopez C.A., Kingsbury D.D., Xavier M.N., Winter S.E., Tsolis R.M., Bäumler A.J. Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration. mBio. 2013;4:e00430-13. doi: 10.1128/mBio.00430-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Biset S., Moges F., Endalamaw D., Eshetie S. Multi-drug resistant and extended-spectrum β-lactamases producing bacterial uropathogens among pregnant women in Northwest Ethiopia. Ann. Clin. Microbiol. Antimicrob. 2020;19:25. doi: 10.1186/s12941-020-00365-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Petca R.C., Negoiță S., Mareș C., Petca A., Popescu R.I., Chibelean C.B. Heterogeneity of Antibiotics Multidrug-Resistance Profile of Uropathogens in Romanian Population. Antibiotics. 2021;10:523. doi: 10.3390/antibiotics10050523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Paterson D.L. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Med. 2006;119((Suppl. S1)):S20–S28; discussion S62–S70. doi: 10.1016/j.amjmed.2006.03.013. [DOI] [PubMed] [Google Scholar]
- 22.Reid G., Sobel J.D. Bacterial adherence in the pathogenesis of urinary tract infection: A review. Rev. Infect. Dis. 1987;9:470–487. doi: 10.1093/clinids/9.3.470. [DOI] [PubMed] [Google Scholar]
- 23.Lane M.C., Alteri C.J., Smith S.N., Mobley H.L. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc. Natl. Acad. Sci. USA. 2007;104:16669–16674. doi: 10.1073/pnas.0607898104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lane M.C., Lockatell V., Monterosso G., Lamphier D., Weinert J., Hebel J.R., Johnson D. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect. Immun. 2005;73:7644–7656. doi: 10.1128/IAI.73.11.7644-7656.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Spaulding C.N., Hultgren S.J. Adhesive Pili in UTI Pathogenesis and Drug Development. Pathog. 2016;5:30. doi: 10.3390/pathogens5010030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Dhakal B.K., Mulvey M.A. The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe. 2012;11:58–69. doi: 10.1016/j.chom.2011.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Garcia T.A., Ventura C.L., Smith M.A., Merrell D.S., O’Brien A.D. Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder. Infect. Immun. 2013;81:99–109. doi: 10.1128/IAI.00605-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Cestari S.E., Ludovico M.S., Martins F.H., da Rocha S.P., Elias W.P., Pelayo J.S. Molecular detection of HpmA and HlyA hemolysin of uropathogenic Proteus mirabilis. Curr. Microbiol. 2013;67:703–707. doi: 10.1007/s00284-013-0423-5. [DOI] [PubMed] [Google Scholar]
- 29.Kosikowska P., Berlicki Ł. Urease inhibitors as potential drugs for gastric and urinary tract infections: A patent review. Expert Opin. Ther. Pat. 2011;21:945–957. doi: 10.1517/13543776.2011.574615. [DOI] [PubMed] [Google Scholar]
- 30.Cathcart G.R., Quinn D., Greer B., Harriott P., Lynas J.F., Gilmore B.F., Walker B. Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: A potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection. Antimicrob. Agents Chemother. 2011;55:2670–2678. doi: 10.1128/AAC.00776-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Song J., Bishop B.L., Li G., Grady R., Stapleton A., Abraham S.N. TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc. Natl. Acad. Sci. USA. 2009;106:14966–14971. doi: 10.1073/pnas.0900527106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hannan T.J., Mysorekar I.U., Hung C.S., Isaacson-Schmid M.L., Hultgren S.J. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog. 2010;6:e1001042. doi: 10.1371/journal.ppat.1001042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Schwab S., Jobin K., Kurts C. Urinary tract infection: Recent insight into the evolutionary arms race between uropathogenic Escherichia coli and our immune system. Nephrol Dial Transplant. 2017;32:1977–1983. doi: 10.1093/ndt/gfx022. [DOI] [PubMed] [Google Scholar]
- 34.Billips B.K., Schaeffer A.J., Klumpp D.J. Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect. Immun. 2008;76:3891–3900. doi: 10.1128/IAI.00069-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hatt J.K., Rather P.N. Role of bacterial biofilms in urinary tract infections. Curr. Top. Microbiol. Immunol. 2008;322:163–192. doi: 10.1007/978-3-540-75418-3_8. [DOI] [PubMed] [Google Scholar]
- 36.Stickler D.J. Bacterial biofilms in patients with indwelling urinary catheters. Nat. Clin. Pract. Urol. 2008;5:598–608. doi: 10.1038/ncpuro1231. [DOI] [PubMed] [Google Scholar]
- 37.Guiton P.S., Hung C.S., Hancock L.E., Caparon M.G., Hultgren S.J. Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections. Infect. Immun. 2010;78:4166–4175. doi: 10.1128/IAI.00711-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Sokurenko E.V., Courtney H.S., Abraham S.N., Klemm P., Hasty D.L. Functional heterogeneity of type 1 fimbriae of Escherichia coli. Infect. Immun. 1992;60:4709–4719. doi: 10.1128/iai.60.11.4709-4719.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Soto S.M., Smithson A., Horcajada J.P., Martinez J.A., Mensa J.P., Vila J. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin. Microbiol. Infect. 2006;12:1034–1036. doi: 10.1111/j.1469-0691.2006.01543.x. [DOI] [PubMed] [Google Scholar]
- 40.Flores-Mireles A.L., Walker J.N., Bauman T.M., Potretzke A.M., Schreiber H.L., Park A.M., Pinkner J.S., Caparon M.G., Hultgren S.J., Desai A. Fibrinogen Release and Deposition on Urinary Catheters Placed during Urological Procedures. J. Urol. 2016;196:416–421. doi: 10.1016/j.juro.2016.01.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Mortimer T.D., Annis D.S., O’Neill M.B., Bohr L.L., Smith T.M., Poinar H.N., Mosher D., Pepperell C. Adaptation in a Fibronectin Binding Autolysin of. mSphere. 2017;2:e00511-17. doi: 10.1128/mSphere.00511-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Luna-Pineda V.M., Moreno-Fierros L., Cázares-Domínguez V., Ilhuicatzi-Alvarado D., Ochoa S.A., Cruz-Córdova A., Valencia-Mayoral P., Rodríguez-Leviz A., Cortes X. Curli of Uropathogenic enhance urinary tract colonization as a fitness factor. Front. Microbiol. 2019;10:2063. doi: 10.3389/fmicb.2019.02063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.D’Alessandro B., Lery L.M., von Krüger W.M., Lima A., Piccini C., Zunino P. Proteomic analysis of Proteus mirabilis outer membrane proteins reveals differential expression in vivo vs. in vitro conditions. FEMS Immunol. Med. Microbiol. 2011;63:174–182. doi: 10.1111/j.1574-695X.2011.00839.x. [DOI] [PubMed] [Google Scholar]
- 44.Selvarangan R., Goluszko P., Singhal J., Carnoy C., Moseley S., Hudson B., Nowicki S., Nowicki B. Interaction of Dr adhesin with collagen type IV is a critical step in Escherichia coli renal persistence. Infect. Immun. 2004;72:4827–4835. doi: 10.1128/IAI.72.8.4827-4835.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Rosen D.A., Hooton T.M., Stamm W.E., Humphrey P.A., Hultgren S.J. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 2007;4:e329. doi: 10.1371/journal.pmed.0040329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Flores-Mireles A.L., Walker J.N., Caparon M., Hultgren S.J. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015;13:269–284. doi: 10.1038/nrmicro3432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Scott V.C., Haake D.A., Churchill B.M., Justice S.S., Kim J.H. Intracellular Bacterial Communities: A Potential Etiology for Chronic Lower Urinary Tract Symptoms. Urology. 2015;86:425–431. doi: 10.1016/j.urology.2015.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Schiwon M., Weisheit C., Franken L., Gutweiler S., Dixit A., Meyer-Schwesinger C., Pohl J.-M., Maurice N., Thiebes S., Lorenz K., et al. Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium. Cell. 2014;156:456–468. doi: 10.1016/j.cell.2014.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Sivick K.E., Schaller M.A., Smith S.N., Mobley H.L. The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J. Immunol. 2010;184:2065–2075. doi: 10.4049/jimmunol.0902386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Justice S.S., Hunstad D.A., Seed P.C., Hultgren S.J. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc. Natl. Acad. Sci. USA. 2006;103:19884–19889. doi: 10.1073/pnas.0606329104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Armbruster C.E., Mobley H.L. Merging mythology and morphology: The multifaceted lifestyle of Proteus mirabilis. Nat. Rev. Microbiol. 2012;10:743–754. doi: 10.1038/nrmicro2890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Morgenstein R.M., Rather P.N. Role of the Umo proteins and the Rcs phosphorelay in the swarming motility of the wild type and an O-antigen (waaL) mutant of Proteus mirabilis. J. Bacteriol. 2012;194:669–676. doi: 10.1128/JB.06047-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Stock A.M., Robinson V.L., Goudreau P.N. Two-component signal transduction. Annu. Rev. Biochem. 2000;69:183–215. doi: 10.1146/annurev.biochem.69.1.183. [DOI] [PubMed] [Google Scholar]
- 54.Wang S. Bacterial Two-Component Systems: Structures and Signaling Mechanisms. In: Huang C., editor. Protein Phosphorylation in Human Health. IntechOpen; London, UK: 2012. [Google Scholar]
- 55.Casino P., Rubio V., Marina A. Structural insight into partner specificity and phosphoryl transfer in two-component signal transduction. Cell. 2009;139:325–336. doi: 10.1016/j.cell.2009.08.032. [DOI] [PubMed] [Google Scholar]
- 56.Bachhawat P., Stock A.M. Crystal structures of the receiver domain of the response regulator PhoP from Escherichia coli in the absence and presence of the phosphoryl analog beryllofluoride. J. Bacteriol. 2007;189:5987–5995. doi: 10.1128/JB.00049-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Galperin M.Y. Diversity of structure and function of response regulator output domains. Curr. Opin. Microbiol. 2010;13:150–159. doi: 10.1016/j.mib.2010.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Sidote D.J., Barbieri C.M., Wu T., Stock A.M. Structure of the Staphylococcus aureus AgrA LytTR domain bound to DNA reveals a beta fold with an unusual mode of binding. Structure. 2008;16:727–735. doi: 10.1016/j.str.2008.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Maris A.E., Sawaya M.R., Kaczor-Grzeskowiak M., Jarvis M.R., Bearson S.M., Kopka M.L., Schröder I., Gunsalus R., Dickerson R. Dimerization allows DNA target site recognition by the NarL response regulator. Nat. Struct. Biol. 2002;9:771–778. doi: 10.1038/nsb845. [DOI] [PubMed] [Google Scholar]
- 60.Liu W., Dong H., Li J., Ou Q., Lv Y., Wang X., Xiang Z., He Y., Wu Q. RNA-seq reveals the critical role of OtpR in regulating Brucella melitensis metabolism and virulence under acidic stress. Sci. Rep. 2015;5:10864. doi: 10.1038/srep10864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Low L.Y., Harrison P.F., Lin Y.H., Boyce J.D., Rood J.I., Cheung J.K. RNA-seq analysis of virR and revR mutants of Clostridium perfringens. BMC Genom. 2016;17:391. doi: 10.1186/s12864-016-2706-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Kaihami G.H., Breda L.C.D., de Almeida J.R.F., de Oliveira Pereira T., Nicastro G.G., Boechat A.L., de Almeida S.R., Baldini R.L. The Atypical Response Regulator AtvR Is a New Player in Pseudomonas aeruginosa Response to Hypoxia and Virulence. Infect. Immun. 2017;85:e00207-17. doi: 10.1128/IAI.00207-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Rajeev L., Garber M.E., Mukhopadhyay A. Tools to map target genes of bacterial two-component system response regulators. Environ. Microbiol. Rep. 2020;12:267–276. doi: 10.1111/1758-2229.12838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Subashchandrabose S., Mobley H.L.T. Virulence and Fitness Determinants of Uropathogenic Escherichia coli. Microbiol. Spectr. 2015;3:10. doi: 10.1128/microbiolspec.UTI-0015-2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Carey A.J., Tan C.K., Ipe D.S., Sullivan M.J., Cripps A.W., Schembri M.A., Ulett G.C. Urinary tract infection of mice to model human disease: Practicalities, implications and limitations. Crit. Rev. Microbiol. 2016;42:780–799. doi: 10.3109/1040841X.2015.1028885. [DOI] [PubMed] [Google Scholar]
- 66.Gotoh Y., Eguchi Y., Watanabe T., Okamoto S., Doi A., Utsumi R. Two-component signal transduction as potential drug targets in pathogenic bacteria. Curr. Opin. Microbiol. 2010;13:232–239. doi: 10.1016/j.mib.2010.01.008. [DOI] [PubMed] [Google Scholar]
- 67.Dhakal B.K., Kulesus R.R., Mulvey M.A. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur. J. Clin. Investig. 2008;38((Suppl. S2)):2–11. doi: 10.1111/j.1365-2362.2008.01986.x. [DOI] [PubMed] [Google Scholar]
- 68.Russo T.A., Johnson J.R. Medical and economic impact of extraintestinal infections due to Escherichia coli: Focus on an increasingly important endemic problem. Microbes Infect. 2003;5:449–456. doi: 10.1016/S1286-4579(03)00049-2. [DOI] [PubMed] [Google Scholar]
- 69.Connell I., Agace W., Klemm P., Schembri M., Mărild S., Svanborg C. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc. Natl. Acad. Sci. USA. 1996;93:9827–9832. doi: 10.1073/pnas.93.18.9827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Bien J., Sokolova O., Bozko P. Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage. Int. J. Nephrol. 2012;2012:681473. doi: 10.1155/2012/681473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Hurst R.E. Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J. Urol. 1994;12:3–10. doi: 10.1007/BF00182044. [DOI] [PubMed] [Google Scholar]
- 72.Parsons C.L., Greenspan C., Moore S.W., Mulholland S.G. Role of surface mucin in primary antibacterial defense of bladder. Urology. 1977;9:48–52. doi: 10.1016/0090-4295(77)90284-9. [DOI] [PubMed] [Google Scholar]
- 73.Floyd K.A., Moore J.L., Eberly A.R., Good J.A., Shaffer C.L., Zaver H., Almqvist F., Skaar E.P., Caprioli R.M., Hadjifrangiskou M. Adhesive fiber stratification in uropathogenic Escherichia coli biofilms unveils oxygen-mediated control of type 1 pili. PLoS Pathog. 2015;11:e1004697. doi: 10.1371/journal.ppat.1004697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Allsopp L.P., Beloin C., Ulett G.C., Valle J., Totsika M., Sherlock O., Ghigo J.-M., Schembri M. Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073. Infect. Immun. 2012;80:321–332. doi: 10.1128/IAI.05322-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Valle J., Mabbett A.N., Ulett G.C., Toledo-Arana A., Wecker K., Totsika M., Schembri M., Ghigo J.-M., Beloin C. UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli. J. Bacteriol. 2008;190:4147–4161. doi: 10.1128/JB.00122-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Hung C., Zhou Y., Pinkner J.S., Dodson K.W., Crowley J.R., Heuser J., Chapman M.R., Hadjifrangiskou M., Henderson J.P., Hultgren S.J. Escherichia coli biofilms have an organized and complex extracellular matrix structure. mBio. 2013;4:e00645-13. doi: 10.1128/mBio.00645-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Plançon L., Du Merle L., Le Friec S., Gounon P., Jouve M., Guignot J., Servin A., Le Bouguénec C. Recognition of the cellular beta1-chain integrin by the bacterial AfaD invasin is implicated in the internalization of afa-expressing pathogenic Escherichia coli strains. Cell Microbiol. 2003;5:681–693. doi: 10.1046/j.1462-5822.2003.00308.x. [DOI] [PubMed] [Google Scholar]
- 78.Li K., Feito M.J., Sacks S.H., Sheerin N.S. CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli. J. Immunol. 2006;177:2543–2551. doi: 10.4049/jimmunol.177.4.2543. [DOI] [PubMed] [Google Scholar]
- 79.Rana T., Hasan R.J., Nowicki S., Venkatarajan M.S., Singh R., Urvil P.T., Popov V., Braun W., Popik W., Goodwin S., et al. Complement protective epitopes and CD55-microtubule complexes facilitate the invasion and intracellular persistence of uropathogenic Escherichia coli. J. Infect. Dis. 2014;209:1066–1076. doi: 10.1093/infdis/jit619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Bens M., Vimont S., Ben Mkaddem S., Chassin C., Goujon J.M., Balloy V., Chignard M., Werts C., Vandewalle A. Flagellin/TLR5 signalling activates renal collecting duct cells and facilitates invasion and cellular translocation of uropathogenic Escherichia coli. Cell Microbiol. 2014;16:1503–1517. doi: 10.1111/cmi.12306. [DOI] [PubMed] [Google Scholar]
- 81.Martinez J.J., Mulvey M.A., Schilling J.D., Pinkner J.S., Hultgren S.J. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 2000;19:2803–2812. doi: 10.1093/emboj/19.12.2803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Bishop B.L., Duncan M.J., Song J., Li G., Zaas D., Abraham S.N. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat. Med. 2007;13:625–630. doi: 10.1038/nm1572. [DOI] [PubMed] [Google Scholar]
- 83.Mulvey M.A., Schilling J.D., Hultgren S.J. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 2001;69:4572–4579. doi: 10.1128/IAI.69.7.4572-4579.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Justice S.S., Hung C., Theriot J.A., Fletcher D.A., Anderson G.G., Footer M.J., Hultgren S.J. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. USA. 2004;101:1333–1338. doi: 10.1073/pnas.0308125100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Eto D.S., Sundsbak J.L., Mulvey M.A. Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell Microbiol. 2006;8:704–717. doi: 10.1111/j.1462-5822.2006.00691.x. [DOI] [PubMed] [Google Scholar]
- 86.Mysorekar I.U., Hultgren S.J. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl. Acad. Sci. USA. 2006;103:14170–14175. doi: 10.1073/pnas.0602136103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Blango M.G., Mulvey M.A. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob. Agents Chemother. 2010;54:1855–1863. doi: 10.1128/AAC.00014-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Sarshar M., Scribano D., Limongi D., Zagaglia C., Palamara A.T., Ambrosi C. Adaptive strategies of uropathogenic Escherichia coli CFT073: From growth in lab media to virulence during host cell adhesion. Int. Microbiol. 2022;25:481–494. doi: 10.1007/s10123-022-00235-y. [DOI] [PubMed] [Google Scholar]
- 89.Ambrosi C., Sarshar M., Aprea M.R., Pompilio A., Di Bonaventura G., Strati F., Pronio A., Nicoletti M., Zagaglia C., Palamara A.T., et al. Colonic adenoma-associated Escherichia coli express specific phenotypes. Microbes Infect. 2019;21:305–312. doi: 10.1016/j.micinf.2019.02.001. [DOI] [PubMed] [Google Scholar]
- 90.Sarshar M., Behzadi P., Ambrosi C., Zagaglia C., Palamara A.T., Scribano D., Fim H., Adhesive A. Therapeutics: A Disarming Strategy Against Uropathogens. Antibiotics. 2020;9:397. doi: 10.3390/antibiotics9070397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Scribano D., Sarshar M., Prezioso C., Lucarelli M., Angeloni A., Zagaglia C., Palamara A.T., Ambrosi C. d-Mannose Treatment neither Affects Uropathogenic Escherichia coli Properties nor Induces Stable FimH Modifications. Molecules. 2020;25:316. doi: 10.3390/molecules25020316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Withman B., Gunasekera T.S., Beesetty P., Agans R., Paliy O. Transcriptional responses of uropathogenic Escherichia coli to increased environmental osmolality caused by salt or urea. Infect. Immun. 2013;81:80–89. doi: 10.1128/IAI.01049-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Rentschler A.E., Lovrich S.D., Fitton R., Enos-Berlage J., Schwan W.R. OmpR regulation of the uropathogenic Escherichia coli fimB gene in an acidic/high osmolality environment. Microbiology. 2013;159:316–327. doi: 10.1099/mic.0.059386-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Igo M.M., Silhavy T.J. EnvZ, a transmembrane environmental sensor of Escherichia coli K-12, is phosphorylated in vitro. J. Bacteriol. 1988;170:5971–5973. doi: 10.1128/jb.170.12.5971-5973.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Cai S.J., Inouye M. EnvZ-OmpR interaction and osmoregulation in Escherichia coli. J. Biol. Chem. 2002;277:24155–24161. doi: 10.1074/jbc.M110715200. [DOI] [PubMed] [Google Scholar]
- 96.Gally D.L., Leathart J., Blomfield I.C. Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12. Mol. Microbiol. 1996;21:725–738. doi: 10.1046/j.1365-2958.1996.311388.x. [DOI] [PubMed] [Google Scholar]
- 97.Schwan W.R. Survival of uropathogenic Escherichia coli in the murine urinary tract is dependent on OmpR. Microbiology. 2009;155:1832–1839. doi: 10.1099/mic.0.026187-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Gerken H., Vuong P., Soparkar K., Misra R. Roles of the EnvZ/OmpR Two-Component System and Porins in Iron Acquisition in. mBio. 2020;11:e01192-20. doi: 10.1128/mBio.01192-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Prohinar P., Forst S.A., Reed D., Mandic-Mulec I., Weiss J. OmpR-dependent and OmpR-independent responses of Escherichia coli to sublethal attack by the neutrophil bactericidal/permeability increasing protein. Mol. Microbiol. 2002;43:1493–1504. doi: 10.1046/j.1365-2958.2002.02804.x. [DOI] [PubMed] [Google Scholar]
- 100.Oshima T., Aiba H., Masuda Y., Kanaya S., Sugiura M., Wanner B.L., Mori H., Mizuno T. Transcriptome analysis of all two-component regulatory system mutants of Escherichia coli K-12. Mol. Microbiol. 2002;46:281–291. doi: 10.1046/j.1365-2958.2002.03170.x. [DOI] [PubMed] [Google Scholar]
- 101.Cai W., Wannemuehler Y., Dell’anna G., Nicholson B., Barbieri N.L., Kariyawasam S., Feng Y., Logue C., Nolan L., Li G. A novel two-component signaling system facilitates uropathogenic Escherichia coli’s ability to exploit abundant host metabolites. PLoS Pathog. 2013;9:e1003428. doi: 10.1371/journal.ppat.1003428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Pritchard J.B. Intracellular alpha-ketoglutarate controls the efficacy of renal organic anion transport. J. Pharmacol. Exp. Ther. 1995;274:1278–1284. [PubMed] [Google Scholar]
- 103.Berry R.E., Klumpp D.J., Schaeffer A.J. Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect. Immun. 2009;77:2762–2772. doi: 10.1128/IAI.00323-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Mulvey M.A., Schilling J.D., Martinez J.J., Hultgren S.J. Bad bugs and beleaguered bladders: Interplay between uropathogenic Escherichia coli and innate host defenses. Proc. Natl. Acad. Sci. USA. 2000;97:8829–8835. doi: 10.1073/pnas.97.16.8829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Smith Y.C., Rasmussen S.B., Grande K.K., Conran R.M., O’Brien A.D. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect. Immun. 2008;76:2978–2990. doi: 10.1128/IAI.00075-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Ristow L.C., Welch R.A. Hemolysin of uropathogenic Escherichia coli: A cloak or a dagger? Biochim. Biophys. Acta. 2016;1858:538–545. doi: 10.1016/j.bbamem.2015.08.015. [DOI] [PubMed] [Google Scholar]
- 107.Welch R.A. Pore-forming cytolysins of gram-negative bacteria. Mol. Microbiol. 1991;5:521–528. doi: 10.1111/j.1365-2958.1991.tb00723.x. [DOI] [PubMed] [Google Scholar]
- 108.Schwidder M., Heinisch L., Schmidt H. Genetics, Toxicity, and Distribution of Enterohemorrhagic. Toxins. 2019;11:502. doi: 10.3390/toxins11090502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Ma Q., Wood T.K. OmpA influences Escherichia coli biofilm formation by repressing cellulose production through the CpxRA two-component system. Environ. Microbiol. 2009;11:2735–2746. doi: 10.1111/j.1462-2920.2009.02000.x. [DOI] [PubMed] [Google Scholar]
- 110.De Wulf P., Kwon O., Lin E.C. The CpxRA signal transduction system of Escherichia coli: Growth-related autoactivation and control of unanticipated target operons. J. Bacteriol. 1999;181:6772–6778. doi: 10.1128/JB.181.21.6772-6778.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Weatherspoon-Griffin N., Zhao G., Kong W., Kong Y., Morigen Andrews-Polymenis H., McClelland M., Shi Y. The CpxR/CpxA two-component system up-regulates two Tat-dependent peptidoglycan amidases to confer bacterial resistance to antimicrobial peptide. J. Biol. Chem. 2011;286:5529–5539. doi: 10.1074/jbc.M110.200352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Mahoney T.F., Silhavy T.J. The Cpx stress response confers resistance to some, but not all, bactericidal antibiotics. J. Bacteriol. 2013;195:1869–1874. doi: 10.1128/JB.02197-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Vogt S.L., Raivio T.L. Just scratching the surface: An expanding view of the Cpx envelope stress response. FEMS Microbiol. Lett. 2012;326:2–11. doi: 10.1111/j.1574-6968.2011.02406.x. [DOI] [PubMed] [Google Scholar]
- 114.Weber R.F., Silverman P.M. The cpx proteins of Escherichia coli K12. Structure of the cpxA polypeptide as an inner membrane component. J. Mol. Biol. 1988;203:467–478. doi: 10.1016/0022-2836(88)90013-7. [DOI] [PubMed] [Google Scholar]
- 115.Prigent-Combaret C., Brombacher E., Vidal O., Ambert A., Lejeune P., Landini P., Dorel C. Complex regulatory network controls initial adhesion and biofilm formation in Escherichia coli via regulation of the csgD gene. J. Bacteriol. 2001;183:7213–7223. doi: 10.1128/JB.183.24.7213-7223.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Dorel C., Lejeune P., Rodrigue A. The Cpx system of Escherichia coli, a strategic signaling pathway for confronting adverse conditions and for settling biofilm communities? Res. Microbiol. 2006;157:306–314. doi: 10.1016/j.resmic.2005.12.003. [DOI] [PubMed] [Google Scholar]
- 117.Inoue T., Shingaki R., Hirose S., Waki K., Mori H., Fukui K. Genome-wide screening of genes required for swarming motility in Escherichia coli K-12. J. Bacteriol. 2007;189:950–957. doi: 10.1128/JB.01294-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Mitobe J., Arakawa E., Watanabe H. A sensor of the two-component system CpxA affects expression of the type III secretion system through posttranscriptional processing of InvE. J. Bacteriol. 2005;187:107–113. doi: 10.1128/JB.187.1.107-113.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Raivio T.L., Popkin D.L., Silhavy T.J. The Cpx envelope stress response is controlled by amplification and feedback inhibition. J. Bacteriol. 1999;181:5263–5272. doi: 10.1128/JB.181.17.5263-5272.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Hunke S., Keller R., Müller V.S. Signal integration by the Cpx-envelope stress system. FEMS Microbiol. Lett. 2012;326:12–22. doi: 10.1111/j.1574-6968.2011.02436.x. [DOI] [PubMed] [Google Scholar]
- 121.Buelow D.R., Raivio T.L. Cpx signal transduction is influenced by a conserved N-terminal domain in the novel inhibitor CpxP and the periplasmic protease DegP. J. Bacteriol. 2005;187:6622–6630. doi: 10.1128/JB.187.19.6622-6630.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Debnath I., Norton J.P., Barber A.E., Ott E.M., Dhakal B.K., Kulesus R.R., Mulvey M.A. The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli. Infect. Immun. 2013;81:1450–1459. doi: 10.1128/IAI.01213-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Nagamatsu K., Hannan T.J., Guest R.L., Kostakioti M., Hadjifrangiskou M., Binkley J., Dodson K., Raivio T., Hultgren S. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc. Natl. Acad. Sci. USA. 2015;112:E871–E880. doi: 10.1073/pnas.1500374112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Craven R.R., Gao X., Allen I.C., Gris D., Wardenburg J.B., McElvania-Tekippe E., Ting J., Duncan J. Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS ONE. 2009;4:e7446. doi: 10.1371/journal.pone.0007446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Mukhopadhyay S., Audia J.P., Roy R.N., Schellhorn H.E. Transcriptional induction of the conserved alternative sigma factor RpoS in Escherichia coli is dependent on BarA, a probable two-component regulator. Mol. Microbiol. 2000;37:371–381. doi: 10.1046/j.1365-2958.2000.01999.x. [DOI] [PubMed] [Google Scholar]
- 126.Mukhopadhyay S., Schellhorn H.E. Identification and characterization of hydrogen peroxide-sensitive mutants of Escherichia coli: Genes that require OxyR for expression. J. Bacteriol. 1997;179:330–338. doi: 10.1128/jb.179.2.330-338.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Suzuki K., Wang X., Weilbacher T., Pernestig A.K., Melefors O., Georgellis D., Babitzke P., Romeo T. Regulatory circuitry of the CsrA/CsrB and BarA/UvrY systems of Escherichia coli. J. Bacteriol. 2002;184:5130–5140. doi: 10.1128/JB.184.18.5130-5140.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Wei B.L., Brun-Zinkernagel A.M., Simecka J.W., Prüss B.M., Babitzke P., Romeo T. Positive regulation of motility and flhDC expression by the RNA-binding protein CsrA of Escherichia coli. Mol. Microbiol. 2001;40:245–256. doi: 10.1046/j.1365-2958.2001.02380.x. [DOI] [PubMed] [Google Scholar]
- 129.Jackson D.W., Suzuki K., Oakford L., Simecka J.W., Hart M.E., Romeo T. Biofilm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli. J. Bacteriol. 2002;184:290–301. doi: 10.1128/JB.184.1.290-301.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Palaniyandi S., Mitra A., Herren C.D., Lockatell C.V., Johnson D.E., Zhu X., Mukhopadhyay S. BarA-UvrY two-component system regulates virulence of uropathogenic E. coli CFT073. PLoS ONE. 2012;7:e31348. doi: 10.1371/journal.pone.0031348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Bodey G.P., Bolivar R., Fainstein V., Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev. Infect. Dis. 1983;5:279–313. doi: 10.1093/clinids/5.2.279. [DOI] [PubMed] [Google Scholar]
- 132.Gilligan P.H. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 1991;4:35–51. doi: 10.1128/CMR.4.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Bodey G.P. Pseudomonas aeruginosa infections in cancer patients: Have they gone away? Curr. Opin. Infect. Dis. 2001;14:403–407. doi: 10.1097/00001432-200108000-00001. [DOI] [PubMed] [Google Scholar]
- 134.Vidal F., Mensa J., Martínez J.A., Almela M., Marco F., Gatell J.M., Richart C., Soriano E., Jiménez de Anta M.T. Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1. Eur. J. Clin. Microbiol. Infect. Dis. 1999;18:473–477. doi: 10.1007/s100960050326. [DOI] [PubMed] [Google Scholar]
- 135.Klausen M., Heydorn A., Ragas P., Lambertsen L., Aaes-Jørgensen A., Molin S., Tolker-Nielsen T. Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol. Microbiol. 2003;48:1511–1524. doi: 10.1046/j.1365-2958.2003.03525.x. [DOI] [PubMed] [Google Scholar]
- 136.Friedman L., Kolter R. Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix. J. Bacteriol. 2004;186:4457–4465. doi: 10.1128/JB.186.14.4457-4465.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Branda S.S., Vik S., Friedman L., Kolter R. Biofilms: The matrix revisited. Trends Microbiol. 2005;13:20–26. doi: 10.1016/j.tim.2004.11.006. [DOI] [PubMed] [Google Scholar]
- 138.Francis V.I., Stevenson E.C., Porter S.L. Two-component systems required for virulence in Pseudomonas aeruginosa. FEMS Microbiol. Lett. 2017;364:fnx104. doi: 10.1093/femsle/fnx104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Thi M.T.T., Wibowo D., Rehm B.H.A. Pseudomonas aeruginosa Biofilms. Int. J. Mol. Sci. 2020;21:8671. doi: 10.3390/ijms21228671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Maurice N.M., Bedi B., Sadikot R.T. Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections. Am. J. Respir. Cell Mol. Biol. 2018;58:428–439. doi: 10.1165/rcmb.2017-0321TR. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Cole S.J., Records A.R., Orr M.W., Linden S.B., Lee V.T. Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms. Infect. Immun. 2014;82:2048–2058. doi: 10.1128/IAI.01652-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Kilmury S.L.N., Burrows L.L. The Pseudomonas aeruginosa PilSR Two-Component System Regulates Both Twitching and Swimming Motilities. mBio. 2018;9:e01310-18. doi: 10.1128/mBio.01310-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Dasgupta N., Wolfgang M.C., Goodman A.L., Arora S.K., Jyot J., Lory S., Ramphal R. A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa. Mol. Microbiol. 2003;50:809–824. doi: 10.1046/j.1365-2958.2003.03740.x. [DOI] [PubMed] [Google Scholar]
- 144.Kulasekara H.D., Ventre I., Kulasekara B.R., Lazdunski A., Filloux A., Lory S. A novel two-component system controls the expression of Pseudomonas aeruginosa fimbrial cup genes. Mol. Microbiol. 2005;55:368–380. doi: 10.1111/j.1365-2958.2004.04402.x. [DOI] [PubMed] [Google Scholar]
- 145.Goodman A.L. Sit and stay a while: How BfiSR controls irreversible attachment in Pseudomonas aeruginosa biofilms. J. Bacteriol. 2010;192:5273–5274. doi: 10.1128/JB.00888-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Leech A.J., Sprinkle A., Wood L., Wozniak D.J., Ohman D.E. The NtrC family regulator AlgB, which controls alginate biosynthesis in mucoid Pseudomonas aeruginosa, binds directly to the algD promoter. J. Bacteriol. 2008;190:581–589. doi: 10.1128/JB.01307-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147.Damron F.H., Owings J.P., Okkotsu Y., Varga J.J., Schurr J.R., Goldberg J.B., Schurr M.J., Yu H.D. Analysis of the Pseudomonas aeruginosa regulon controlled by the sensor kinase KinB and sigma factor RpoN. J. Bacteriol. 2012;194:1317–1330. doi: 10.1128/JB.06105-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148.Chand N.S., Lee J.S., Clatworthy A.E., Golas A.J., Smith R.S., Hung D.T. The sensor kinase KinB regulates virulence in acute Pseudomonas aeruginosa infection. J. Bacteriol. 2011;193:2989–2999. doi: 10.1128/JB.01546-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Petrova O.E., Schurr J.R., Schurr M.J., Sauer K. The novel Pseudomonas aeruginosa two-component regulator BfmR controls bacteriophage-mediated lysis and DNA release during biofilm development through PhdA. Mol. Microbiol. 2011;81:767–783. doi: 10.1111/j.1365-2958.2011.07733.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Cao Q., Wang Y., Chen F., Xia Y., Lou J., Zhang X., Yang N., Sun X., Zhang Q., Zhuo C., et al. A novel signal transduction pathway that modulates rhl quorum sensing and bacterial virulence in Pseudomonas aeruginosa. PLoS Pathog. 2014;10:e1004340. doi: 10.1371/journal.ppat.1004340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Cao Q., Yang N., Wang Y., Xu C., Zhang X., Fan K., Chen F., Liang H., Zhang Y., Deng X., et al. Mutation-induced remodeling of the BfmRS two-component system in Pseudomonas aeruginosa clinical isolates. Sci. Signal. 2020;13:eaaz1529. doi: 10.1126/scisignal.aaz1529. [DOI] [PubMed] [Google Scholar]
- 152.Giraud C., Bernard C.S., Calderon V., Yang L., Filloux A., Molin S., Fichant G., Bordi C., de Bentzmann S. The PprA-PprB two-component system activates CupE, the first non-archetypal Pseudomonas aeruginosa chaperone-usher pathway system assembling fimbriae. Environ. Microbiol. 2011;13:666–683. doi: 10.1111/j.1462-2920.2010.02372.x. [DOI] [PubMed] [Google Scholar]
- 153.Dong Y.H., Zhang X.F., An S.W., Xu J.L., Zhang L.H. A novel two-component system BqsS-BqsR modulates quorum sensing-dependent biofilm decay in Pseudomonas aeruginosa. Commun. Integr. Biol. 2008;1:88–96. doi: 10.4161/cib.1.1.6717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Glick R., Gilmour C., Tremblay J., Satanower S., Avidan O., Déziel E., Greenberg E.P., Poole K., Banin E. Increase in rhamnolipid synthesis under iron-limiting conditions influences surface motility and biofilm formation in Pseudomonas aeruginosa. J. Bacteriol. 2010;192:2973–2980. doi: 10.1128/JB.01601-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 155.Tielen P., Narten M., Rosin N., Biegler I., Haddad I., Hogardt M., Neubauer R., Schobert M., Wiehlmann L., Jahn D. Genotypic and phenotypic characterization of Pseudomonas aeruginosa isolates from urinary tract infections. Int. J. Med. Microbiol. 2011;301:282–292. doi: 10.1016/j.ijmm.2010.10.005. [DOI] [PubMed] [Google Scholar]
- 156.Jimenez P.N., Koch G., Thompson J.A., Xavier K.B., Cool R.H., Quax W.J. The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 2012;76:46–65. doi: 10.1128/MMBR.05007-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157.Guragain M., King M.M., Williamson K.S., Pérez-Osorio A.C., Akiyama T., Khanam S., Patrauchan M.A., Franklin M.J. The Pseudomonas aeruginosa PAO1 Two-Component Regulator CarSR Regulates Calcium Homeostasis and Calcium-Induced Virulence Factor Production through Its Regulatory Targets CarO and CarP. J. Bacteriol. 2016;198:951–963. doi: 10.1128/JB.00963-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 158.Hospenthal M., Costa T., Waksman G.A. Comprehensive guide to pilus biogenesis in Gram-negative bacteria. Nat. Rev. Microbiol. 2017;15:365–379. doi: 10.1038/nrmicro.2017.40. [DOI] [PubMed] [Google Scholar]
- 159.Marko V.A., Kilmury S.L.N., MacNeil L.T., Burrows L.L. Pseudomonas aeruginosa type IV minor pilins and PilY1 regulate virulence by modulating FimS-AlgR activity. PLoS Pathog. 2018;14:e1007074. doi: 10.1371/journal.ppat.1007074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Bertrand J.J., West J.T., Engel J.N. Genetic analysis of the regulation of type IV pilus function by the Chp chemosensory system of Pseudomonas aeruginosa. J. Bacteriol. 2010;192:994–1010. doi: 10.1128/JB.01390-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 161.Britigan B.E., Roeder T.L., Rasmussen G.T., Shasby D.M., McCormick M.L., Cox C.D. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for Pseudomonas-associated tissue injury. J. Clin. Investig. 1992;90:2187–2196. doi: 10.1172/JCI116104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 162.Mavrodi D.V., Bonsall R.F., Delaney S.M., Soule M.J., Phillips G., Thomashow L.S. Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from Pseudomonas aeruginosa PAO1. J. Bacteriol. 2001;183:6454–6465. doi: 10.1128/JB.183.21.6454-6465.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163.Okkotsu Y., Tieku P., Fitzsimmons L.F., Churchill M.E., Schurr M.J. Pseudomonas aeruginosa AlgR phosphorylation modulates rhamnolipid production and motility. J. Bacteriol. 2013;195:5499–5515. doi: 10.1128/JB.00726-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164.Galloway D.R. Pseudomonas aeruginosa elastase and elastolysis revisited: Recent developments. Mol. Microbiol. 1991;5:2315–2321. doi: 10.1111/j.1365-2958.1991.tb02076.x. [DOI] [PubMed] [Google Scholar]
- 165.Foulkes D.M., McLean K., Haneef A.S., Fernig D.G., Winstanley C., Berry N., Kaye S.B. Pseudomonas aeruginosa Toxin ExoU as a Therapeutic Target in the Treatment of Bacterial Infections. Microorganisms. 2019;7:707. doi: 10.3390/microorganisms7120707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166.Woods D.E., Schaffer M.S., Rabin H.R., Campbell G.D., Sokol P.A. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J. Clin. Microbiol. 1986;24:260–264. doi: 10.1128/jcm.24.2.260-264.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167.Daddaoua A., Molina-Santiago C., de la Torre J., Krell T., Ramos J.L. GtrS and GltR form a two-component system: The central role of 2-ketogluconate in the expression of exotoxin A and glucose catabolic enzymes in Pseudomonas aeruginosa. Nucleic Acids Res. 2014;42:7654–7663. doi: 10.1093/nar/gku496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168.Xu C., Cao Q., Lan L. Glucose-Binding of Periplasmic Protein GltB Activates GtrS-GltR Two-Component System in Pseudomonas aeruginosa. Microorganisms. 2021;9:447. doi: 10.3390/microorganisms9020447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169.Sultan M., Arya R., Kim K.K. Roles of Two-Component Systems in Pseudomonas aeruginosa Virulence. Int. J. Mol. Sci. 2021;22:1215. doi: 10.3390/ijms222212152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 170.Yeung A.T., Bains M., Hancock R.E. The sensor kinase CbrA is a global regulator that modulates metabolism, virulence, and antibiotic resistance in Pseudomonas aeruginosa. J. Bacteriol. 2011;193:918–931. doi: 10.1128/JB.00911-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 171.Yeung A.T., Janot L., Pena O.M., Neidig A., Kukavica-Ibrulj I., Hilchie A., Levesque R.C., Overhage J., Hancock R.E. Requirement of the Pseudomonas aeruginosa CbrA sensor kinase for full virulence in a murine acute lung infection model. Infect. Immun. 2014;82:1256–1267. doi: 10.1128/IAI.01527-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 172.Wu W., Badrane H., Arora S., Baker H.V., Jin S. MucA-mediated coordination of type III secretion and alginate synthesis in Pseudomonas aeruginosa. J. Bacteriol. 2004;186:7575–7585. doi: 10.1128/JB.186.22.7575-7585.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 173.Pang Z., Raudonis R., Glick B.R., Lin T.J., Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies. Biotechnol. Adv. 2019;37:177–192. doi: 10.1016/j.biotechadv.2018.11.013. [DOI] [PubMed] [Google Scholar]
- 174.Penaranda C., Chumbler N.M., Hung D.T. Dual transcriptional analysis reveals adaptation of host and pathogen to intracellular survival of Pseudomonas aeruginosa associated with urinary tract infection. PLoS Pathog. 2021;17:e1009534. doi: 10.1371/journal.ppat.1009534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 175.Okkotsu Y., Little A.S., Schurr M.J. The Pseudomonas aeruginosa AlgZR two-component system coordinates multiple phenotypes. Front. Cell. Infect. Microbiol. 2014;4:82. doi: 10.3389/fcimb.2014.00082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 176.Westermann A.J., Barquist L., Vogel J. Resolving host-pathogen interactions by dual RNA-seq. PLoS Pathog. 2017;13:e1006033. doi: 10.1371/journal.ppat.1006033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177.Frisk A., Schurr J.R., Wang G., Bertucci D.C., Marrero L., Hwang S.H., Hassett D.J., Schurr M.J. Transcriptome analysis of Pseudomonas aeruginosa after interaction with human airway epithelial cells. Infect. Immun. 2004;72:5433–5438. doi: 10.1128/IAI.72.9.5433-5438.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 178.Damron F.H., Oglesby-Sherrouse A.G., Wilks A., Barbier M. Dual-seq transcriptomics reveals the battle for iron during Pseudomonas aeruginosa acute murine pneumonia. Sci. Rep. 2016;6:39172. doi: 10.1038/srep39172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 179.Bader M.S., Loeb M., Leto D., Brooks A.A. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad. Med. 2020;132:234–250. doi: 10.1080/00325481.2019.1680052. [DOI] [PubMed] [Google Scholar]
- 180.Delnay K.M., Stonehill W.H., Goldman H., Jukkola A.F., Dmochowski R.R. Bladder histological changes associated with chronic indwelling urinary catheter. J. Urol. 1999;161:1106–1108; discussion 8–9. doi: 10.1016/S0022-5347(01)61601-X. [DOI] [PubMed] [Google Scholar]
- 181.Guiton P.S., Hannan T.J., Ford B., Caparon M.G., Hultgren S.J. Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections. Infect. Immun. 2013;81:329–339. doi: 10.1128/IAI.00856-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 182.Flores-Mireles A.L., Pinkner J.S., Caparon M.G., Hultgren S.J. EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice. Sci. Transl. Med. 2014;6:254ra127. doi: 10.1126/scitranslmed.3009384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 183.Kowalski W.J., Kasper E.L., Hatton J.F., Murray B.E., Nallapareddy S.R., Gillespie M.J. Enterococcus faecalis adhesin, Ace, mediates attachment to particulate dentin. J. Endod. 2006;32:634–637. doi: 10.1016/j.joen.2005.12.005. [DOI] [PubMed] [Google Scholar]
- 184.Nallapareddy S.R., Qin X., Weinstock G.M., Höök M., Murray B.E. Enterococcus faecalis adhesin, ace, mediates attachment to extracellular matrix proteins collagen type IV and laminin as well as collagen type I. Infect. Immun. 2000;68:5218–5224. doi: 10.1128/IAI.68.9.5218-5224.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 185.Sillanpää J., Nallapareddy S.R., Houston J., Ganesh V.K., Bourgogne A., Singh K.V., Murray B.E., Höök M. A family of fibrinogen-binding MSCRAMMs from Enterococcus faecalis. Microbiol. 2009;155:2390–2400. doi: 10.1099/mic.0.027821-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 186.Sava I.G., Zhang F., Toma I., Theilacker C., Li B., Baumert T.F., Holst O., Linhardt R.J., Huebner J. Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cells. J. Biol. Chem. 2009;284:18194–18201. doi: 10.1074/jbc.M901460200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 187.Cobo Molinos A., Abriouel H., Omar N.B., López R.L., Galvez A. Detection of ebp (endocarditis- and biofilm-associated pilus) genes in enterococcal isolates from clinical and non-clinical origin. Int. J. Food Microbiol. 2008;126:123–126. doi: 10.1016/j.ijfoodmicro.2008.05.015. [DOI] [PubMed] [Google Scholar]
- 188.Nallapareddy S.R., Singh K.V., Sillanpää J., Garsin D.A., Höök M., Erlandsen S.L., Murray B.E. Endocarditis and biofilm-associated pili of Enterococcus faecalis. J. Clin. Investig. 2006;116:2799–2807. doi: 10.1172/JCI29021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 189.Nakayama J., Chen S., Oyama N., Nishiguchi K., Azab E.A., Tanaka E., Kariyama R., Sonomoto K. Revised model for Enterococcus faecalis fsr quorum-sensing system: The small open reading frame fsrD encodes the gelatinase biosynthesis-activating pheromone propeptide corresponding to staphylococcal agrd. J. Bacteriol. 2006;188:8321–8326. doi: 10.1128/JB.00865-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 190.Roh J.H., Singh K.V., La Rosa S.L., Cohen A.L., Murray B.E. The two-component system GrvRS (EtaRS) regulates ace expression in Enterococcus faecalis OG1RF. Infect. Immun. 2015;83:389–395. doi: 10.1128/IAI.02587-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 191.Campbell J.R., Hillier S.L., Krohn M.A., Ferrieri P., Zaleznik D.F., Baker C.J. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet. Gynecol. 2000;96:498–503. doi: 10.1016/s0029-7844(00)00977-7. [DOI] [PubMed] [Google Scholar]
- 192.Le Doare K., Heath P.T. An overview of global GBS epidemiology. Vaccine. 2013;31:D7–D12. doi: 10.1016/j.vaccine.2013.01.009. [DOI] [PubMed] [Google Scholar]
- 193.Berner R. Group B streptococci during pregnancy and infancy. Curr. Opin. Infect. Dis. 2002;15:307–313. doi: 10.1097/00001432-200206000-00015. [DOI] [PubMed] [Google Scholar]
- 194.Edwards M.S., Baker C.J. Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 2005;41:839–847. doi: 10.1086/432804. [DOI] [PubMed] [Google Scholar]
- 195.Tan C.K., Ulett K.B., Steele M., Benjamin W.H., Ulett G.C. Prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: A 4-year retrospective study in adult patients. BMC Infect. Dis. 2012;12:273. doi: 10.1186/1471-2334-12-273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 196.Ulett K.B., Benjamin W.H., Zhuo F., Xiao M., Kong F., Gilbert G.L., Schembri M.A., Ulett G.C. Diversity of group B streptococcus serotypes causing urinary tract infection in adults. J. Clin. Microbiol. 2009;47:2055–2060. doi: 10.1128/JCM.00154-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 197.Farley M.M. Group B streptococcal disease in nonpregnant adults. Clin. Infect. Dis. 2001;33:556–561. doi: 10.1086/322696. [DOI] [PubMed] [Google Scholar]
- 198.Anderson B.L., Simhan H.N., Simons K.M., Wiesenfeld H.C. Untreated asymptomatic group B streptococcal bacteriuria early in pregnancy and chorioamnionitis at delivery. Am. J. Obstet. Gynecol. 2007;196:524.e1–524.e5. doi: 10.1016/j.ajog.2007.01.006. [DOI] [PubMed] [Google Scholar]
- 199.Møller M., Thomsen A.C., Borch K., Dinesen K., Zdravkovic M. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet. 1984;2:69–70. doi: 10.1016/S0140-6736(84)90242-3. [DOI] [PubMed] [Google Scholar]
- 200.McKenna D.S., Matson S., Northern I. Maternal group B streptococcal (GBS) genital tract colonization at term in women who have asymptomatic GBS bacteriuria. Infect. Dis. Obstet. Gynecol. 2003;11:203–207. doi: 10.1080/10647440300025522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 201.Kessous R., Weintraub A.Y., Sergienko R., Lazer T., Press F., Wiznitzer A., Sheiner E. Bacteruria with group-B streptococcus: Is it a risk factor for adverse pregnancy outcomes? J. Matern. Fetal Neonatal Med. 2012;25:1983–1986. doi: 10.3109/14767058.2012.671872. [DOI] [PubMed] [Google Scholar]
- 202.Schrag S., Gorwitz R., Fultz-Butts K., Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm. Rep. 2002;51:1–22. [PubMed] [Google Scholar]
- 203.Kline K.A., Schwartz D.J., Lewis W.G., Hultgren S.J., Lewis A.L. Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection. Infect. Immun. 2011;79:3588–3595. doi: 10.1128/IAI.00122-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 204.Ulett G.C., Webb R.I., Ulett K.B., Cui X., Benjamin W.H., Crowley M., Schembri M.A. Group B Streptococcus (GBS) urinary tract infection involves binding of GBS to bladder uroepithelium and potent but GBS-specific induction of interleukin 1alpha. J. Infect. Dis. 2010;201:866–870. doi: 10.1086/650696. [DOI] [PubMed] [Google Scholar]
- 205.Patras K.A., Coady A., Babu P., Shing S.R., Ha A.D., Rooholfada E., Brandt S.L., Geriak M., Gallo R., Nizet V. Host Cathelicidin Exacerbates Group B Streptococcus urinary tract infection. mSphere. 2020;5:e00932-19. doi: 10.1128/mSphere.00932-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 206.Rosini R., Margarit I. Biofilm formation by Streptococcus agalactiae: Influence of environmental conditions and implicated virulence factors. Front. Cell. Infect. Microbiol. 2015;5:6. doi: 10.3389/fcimb.2015.00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 207.Shabayek S., Spellerberg B. Acid Stress Response Mechanisms of Group B Streptococci. Front. Cell. Infect. Microbiol. 2017;7:395. doi: 10.3389/fcimb.2017.00395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 208.Thomas L., Cook L. Two-Component Signal Transduction Systems in the Human Pathogen Streptococcus agalactiae. Infect. Immun. 2020;88:e00931-19. doi: 10.1128/IAI.00931-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 209.Lentini G., Midiri A., Firon A., Galbo R., Mancuso G., Biondo C., Mazzon E., Passantino A., Romeo L., Trieu-Cuot P., et al. The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci. Sci. Rep. 2018;8:14322. doi: 10.1038/s41598-018-32774-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 210.Lembo A., Gurney M.A., Burnside K., Banerjee A., de los Reyes M., Connelly J., Lin W.-J., Jewell K., Vo A., Renken C., et al. Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration. Mol. Microbiol. 2010;77:431–443. doi: 10.1111/j.1365-2958.2010.07215.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 211.Patras K.A., Wang N.Y., Fletcher E.M., Cavaco C., Jimenez A., Garg M., Fierer J., Sheen T., Rajagopal L., Doran K. Group B Streptococcus CovR regulation modulates host immune signalling pathways to promote vaginal colonization. Cell Microbiol. 2013;15:1154–1167. doi: 10.1111/cmi.12105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 212.Joubert L., Dagieu J.B., Fernandez A., Derré-Bobillot A., Borezée-Durant E., Fleurot I., Gruss A. Visualization of the role of host heme on the virulence of the heme auxotroph Streptococcus agalactiae. Sci. Rep. 2017;7:40435. doi: 10.1038/srep40435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 213.Deng L., Mu R., Weston T.A., Spencer B.L., Liles R.P., Doran K.S. Characterization of a Two-Component System Transcriptional Regulator, LtdR, That Impacts Group B Streptococcal Colonization and Disease. Infect. Immun. 2018;86:e00822-17. doi: 10.1128/IAI.00822-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 214.Faralla C., Metruccio M.M., De Chiara M., Mu R., Patras K., Muzzi A., Grandi G., Margarit I., Doran K., Janulczyk R. Analysis of two-component systems in group B Streptococcus shows that RgfAC and the novel FspSR modulate virulence and bacterial fitness. mBio. 2014;5:e00870-14. doi: 10.1128/mBio.00870-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 215.Gendrin C., Lembo A., Whidbey C., Burnside K., Berry J., Ngo L., Banerjee A., Xue L., Arrington J., Doran K. The sensor histidine kinase RgfC affects group B streptococcal virulence factor expression independent of its response regulator RgfA. Infect. Immun. 2015;83:1078–1088. doi: 10.1128/IAI.02738-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 216.Cook L.C.C., Hu H., Maienschein-Cline M., Federle M.J. A Vaginal Tract Signal Detected by the Group B Streptococcus SaeRS System Elicits Transcriptomic Changes and Enhances Murine Colonization. Infect. Immun. 2018;86:e00762-17. doi: 10.1128/IAI.00762-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 217.Klinzing D.C., Ishmael N., Hotopp J.C.D., Tettelin H., Shields K.R., Madoff L.C., Puopolo K.M. The two-component response regulator LiaR regulates cell wall stress responses, pili expression and virulence in group B Streptococcus. Microbiology. 2013;159:1521–1534. doi: 10.1099/mic.0.064444-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 218.Yang Y., Luo M., Zhou H., Li C., Luk A., Zhao G., Fung K., Ip M. Role of two-component system response regulator bceR in the antimicrobial resistance, virulence, biofilm formation, and stress response of group B Streptococcus. Front. Microbiol. 2019;10:10. doi: 10.3389/fmicb.2019.00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 219.Quach D., van Sorge N.M., Kristian S.A., Bryan J.D., Shelver D.W., Doran K.S. The CiaR response regulator in group B Streptococcus promotes intracellular survival and resistance to innate immune defenses. J. Bacteriol. 2009;191:2023–2032. doi: 10.1128/JB.01216-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 220.Jiang S.M., Cieslewicz M.J., Kasper D.L., Wessels M.R. Regulation of virulence by a two-component system in group B streptococcus. J. Bacteriol. 2005;187:1105–1113. doi: 10.1128/JB.187.3.1105-1113.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 221.Lamy M.C., Zouine M., Fert J., Vergassola M., Couve E., Pellegrini E., Glaser P., Kunst F., Msadek T., Trieu-Cuot P., et al. CovS/CovR of group B streptococcus: A two-component global regulatory system involved in virulence. Mol. Microbiol. 2004;54:1250–1268. doi: 10.1111/j.1365-2958.2004.04365.x. [DOI] [PubMed] [Google Scholar]
- 222.Rajagopal L., Vo A., Silvestroni A., Rubens C.E. Regulation of cytotoxin expression by converging eukaryotic-type and two-component signalling mechanisms in Streptococcus agalactiae. Mol. Microbiol. 2006;62:941–957. doi: 10.1111/j.1365-2958.2006.05431.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 223.Tazi A., Disson O., Bellais S., Bouaboud A., Dmytruk N., Dramsi S., Mistou M.-Y., Khun H., Mechler C., Tardieux I., et al. The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J. Exp. Med. 2010;207:2313–2322. doi: 10.1084/jem.20092594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 224.Buscetta M., Firon A., Pietrocola G., Biondo C., Mancuso G., Midiri A., Romeo L., Galbo R., Venza M., Venza I., et al. PbsP, a cell wall-anchored protein that binds plasminogen to promote hematogenous dissemination of group B Streptococcus. Mol. Microbiol. 2016;101:27–41. doi: 10.1111/mmi.13357. [DOI] [PubMed] [Google Scholar]
- 225.De Gaetano G.V., Pietrocola G., Romeo L., Galbo R., Lentini G., Giardina M., Biondo C., Midiri A., Mancuso G., Venza M., et al. The Streptococcus agalactiae cell wall-anchored protein PbsP mediates adhesion to and invasion of epithelial cells by exploiting the host vitronectin/α integrin axis. Mol. Microbiol. 2018;110:82–94. doi: 10.1111/mmi.14084. [DOI] [PubMed] [Google Scholar]
- 226.Coppolino F., Romeo L., Pietrocola G., Lentini G., De Gaetano G.V., Teti G., Galbo R., Beninati C. Lysine Residues in the MK-Rich Region Are Not Required for Binding of the PbsP Protein From Group B Streptococci to Plasminogen. Front. Cell. Infect. Microbiol. 2021;11:679792. doi: 10.3389/fcimb.2021.679792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 227.Sullivan M.J., Leclercq S.Y., Ipe D.S., Carey A., Smith J., Voller N., Cripps A., Ulett G. Effect of the Streptococcus agalactiae Virulence Regulator CovR on the Pathogenesis of Urinary Tract Infection. J. Infect. Dis. 2017;215:475–483. doi: 10.1093/infdis/jiw589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 228.Firon A., Tazi A., Da Cunha V., Brinster S., Sauvage E., Dramsi S., Golenbock D.T., Glaser P., Poyart C., Trieu-Cuot P. The Abi-domain protein Abx1 interacts with the CovS histidine kinase to control virulence gene expression in group B Streptococcus. PLoS Pathog. 2013;9:e1003179. doi: 10.1371/journal.ppat.1003179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 229.Jacobsen S.M., Stickler D.J., Mobley H.L.T., Shirtliff M.E. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 2008;21:26–59. doi: 10.1128/CMR.00019-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 230.Nicolle L.E. Catheter-related urinary tract infection. Drugs Aging. 2005;22:627–639. doi: 10.2165/00002512-200522080-00001. [DOI] [PubMed] [Google Scholar]
- 231.Old D.C., Adegbola R.A. Haemagglutinins and fimbriae of Morganella, Proteus and Providencia. J. Med. Microbiol. 1982;15:551. doi: 10.1099/00222615-15-4-551. [DOI] [PubMed] [Google Scholar]
- 232.Bahrani F.K., Mobley H.L.T. Proteus mirabilis MR/P fimbrial operon: Genetic organization, nucleotide sequence, and conditions for expression. J. Bacteriol. 1994;176:3412–3419. doi: 10.1128/jb.176.11.3412-3419.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 233.Rocha S.P.D., Pelayo J.S., Waldir P. Elias, Fimbriae of uropathogenic Proteus mirabilis. FEMS Immun. Med. Microbiol. 2007;51:1–7. doi: 10.1111/j.1574-695X.2007.00284.x. [DOI] [PubMed] [Google Scholar]
- 234.Griffith D.P., Musher D.M., Itin C. Urease. The primary cause of infection-induced urinary stones. Investig. Urol. 1976;13:346–350. [PubMed] [Google Scholar]
- 235.Chew R., Thomas S., Mantha M.L., Killen J.P., Cho Y., Baer R.A. Large urate cystolith associated with Proteus urinary tract infection. Kidney Int. 2012;81:802. doi: 10.1038/ki.2011.506. [DOI] [PubMed] [Google Scholar]
- 236.Jones B.V., Mahenthiralingam E., Sabbuba N.A., Stickler D.J. Role of swarming in the formation of crystalline Proteus mirabilis biofilms on urinary catheters. J. Med. Microbiol. 2005;54:807–813. doi: 10.1099/jmm.0.46123-0. [DOI] [PubMed] [Google Scholar]
- 237.Li X., Zhao H., Lockatell C.V., Drachenberg C.B., Johnson D.E., Mobley H.L.T. Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect. Immun. 2002;70:389–394. doi: 10.1128/IAI.70.1.389-394.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 238.Jones B.D., Lockatell C.V., Johnson D.E., Warren J.W., Mobley H.L.T. Construction of a urease-negative mutant of Proteus mirabilis: Analysis of virulence in a mouse model of ascending urinary tract infection. Infect. Immun. 1990;58:1120–1123. doi: 10.1128/iai.58.4.1120-1123.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 239.Sabbuba N., Hughes G., Stickler D.J. The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters. BJU Int. 2002;89:55–60. doi: 10.1046/j.1464-410X.2002.02560.x. [DOI] [PubMed] [Google Scholar]
- 240.Stickler D., Hughes G. Ability of Proteus mirabilis to swarm over urethral catheters. Eur. J. Clin. Microbiol. Infect. Dis. 1999;18:206–208. doi: 10.1007/s100960050260. [DOI] [PubMed] [Google Scholar]
- 241.Jones B.V., Young R., Mahenthiralingam E., Stickler D.J. Ultrastructure of Proteus mirabilis swarmer cell rafts and role of swarming in catheter-associated urinary tract infection. Infect. Immun. 2004;72:3941–3950. doi: 10.1128/IAI.72.7.3941-3950.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 242.Jones S.M., Yerly J., Hu Y., Ceri H., Martinuzzi R. Structure of Proteus mirabilis biofilms grown in artificial urine and standard laboratory media. FEMS Microbiol. Lett. 2007;268:16–21. doi: 10.1111/j.1574-6968.2006.00587.x. [DOI] [PubMed] [Google Scholar]
- 243.Jiang S.S., Liu M.C., Teng L.J., Wang W.B., Hsueh P.R., Liaw S.J. Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion. Antimicrob. Agents Chemother. 2010;54:1564–1571. doi: 10.1128/AAC.01219-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 244.Wang W.B., Chen I.C., Jiang S.S., Chen H.R., Hsu C.Y., Hsueh P.R., Hsu W.B., Liaw S.J. Role of RppA in the regulation of polymyxin b susceptibility, swarming, and virulence factor expression in Proteus mirabilis. Infect. Immun. 2008;76:2051–2062. doi: 10.1128/IAI.01557-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 245.Lin W.Y., Lee Y.J., Yu P.H., Tsai Y.L., She P.Y., Li T.S., Liaw S.J. The QseEF Two-Component System-GlmY Small RNA Regulatory Pathway Controls Swarming in Uropathogenic Proteus mirabilis. Int. J. Mol. Sci. 2022;23:487. doi: 10.3390/ijms23010487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 246.Lecuru M., Nicolas-Chanoine M.H., Tanaka S., Montravers P., Armand-Lefevre L., Denamur E., Mammeri H. Emergence of Imipenem Resistance in a CpxA-H208P-Variant-Producing Proteus mirabilis Clinical Isolate. Microb. Drug Resist. 2021;27:747–751. doi: 10.1089/mdr.2020.0295. [DOI] [PubMed] [Google Scholar]
- 247.Masi M., Pinet E., Pagès J.M. Complex Response of the CpxAR Two-Component System to β-Lactams on Antibiotic Resistance and Envelope Homeostasis in Enterobacteriaceae. Antimicrob. Agents Chemother. 2020;64:e00291-20. doi: 10.1128/AAC.00291-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 248.Tierney A.R., Rather P.N. Roles of two-component regulatory systems in antibiotic resistance. Future Microbiol. 2019;14:533–552. doi: 10.2217/fmb-2019-0002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 249.Stock J.B., Ninfa A.J., Stock A.M. Protein phosphorylation and regulation of adaptive responses in bacteria. Microbiol. Rev. 1989;53:450–490. doi: 10.1128/mr.53.4.450-490.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 250.Feher V.A., Zapf J.W., Hoch J.A., Whiteley J.M., McIntosh L.P., Rance M., Skelton N.J., Dahlquist F.W., Cavanagh J. High-resolution NMR structure and backbone dynamics of the Bacillus subtilis response regulator, Spo0F: Implications for phosphorylation and molecular recognition. Biochemistry. 1997;36:10015–10025. doi: 10.1021/bi970816l. [DOI] [PubMed] [Google Scholar]
- 251.Barrett J.F., Hoch J.A. Two-component signal transduction as a target for microbial anti-infective therapy. Antimicrob. Agents Chemother. 1998;42:1529–1536. doi: 10.1128/AAC.42.7.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Not applicable.